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2. Summary 
Serine/threonine kinases of the nuclear Dbf2-related (NDR) family are highly 
conserved throughout the eukaryotic world. Members of this kinase family are 
implicated in various aspects of the regulation of cell division and cell morphology. It 
has been shown that the function of several NDR kinases is dependent on proteins of 
the Mob (MPS one binder) family. MOB proteins are highly conserved throughout the 
eukaryotic world as well, which indicates the existence of a novel conserved signalling 
pathway. 
The current work focuses on the mechanism of activation of human NDR kinase by 
the human MOB1 protein. hMOB1 directly activates NDR by binding to the N-
terminal domain of NDR, thereby hMOB1 acts as a kinase activating subunit of NDR 
kinase. The binding induces the release of an autoinhibition caused by an 
autoinhibitory sequence (AIS) and leads to increased phosphorylation of NDR kinase 
on the two important regulatory phosphorylation sites Ser-281 and Thr-444.  
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3. General Introduction 
 
3.1.  Signal transduction 
3.1.1.  Overview 
Cells in multicellular organisms communicate with each other to coordinate their 
growth and differentiation, and the biological processes of a cell have to be performed 
in a coordinated manner. Signalling cascades can be initiated extracellularly (binding 
of a ligand to a membrane receptor initiate a signalling cascade, Karin and Hunter, 
1995) as well as intracellularly (e.g. mitotic checkpoints, Elledge, 1996). Signals have 
to be integrated to induce finally the proper physiological response, so signal 
transduction cascades consist in fact rather of networks than of simple linear pathways 
(Bhalla and Iyengar, 1999). 
Classically, a signal transduction pathway is initiated by the binding of a ligand to its 
receptor in the cell membrane, the receptor transduces the signal into the cell to other 
signalling molecules, and finally, after transduction of the signal over several steps, 
the appropriate biological response is induced (Seger and Krebs, 1995).  
The final targets of signal transduction cascades are the regulation of gene expression 
or the direct modulation of already existing enzymes or other cell components to 
induce a biological response (Keegan and Zamorano, 1998). 
Signal transduction serves to respond to extracellular signals or to intracellular events 
and leads to the regulation of cell growth and cell division, cellular metabolism, cell 
morphology and cell differentiation (Abraham, 2002; Jones and Kazlauskas, 2001; 
Vaudry et al., 2002; Stachowiak et al, 2003; Fanto and McNeill, 2004; Knust, 2001). 
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3.1.2.  Signalling molecules 
There is a wide range of molecules that are involved in signal transduction cascades. 
Receptor proteins serve to transduce a signal from outside the cell into the cell. The 
binding of the appropriate ligand (in some cases other stimuli) induces a 
conformational change of the receptor that results in transduction of the signal 
(Janeway et al, 1989). This is achieved by several mechanisms depending on the 
receptor type: activation of kinase activity by dimerisation/oligomerisation and 
autophosphorylation, recruiting of other molecules to the receptor (receptor tyrosine 
kinases, Taha and Klip, 1999, receptor serine/threonine kinases, Lin et al, 1992), 
association with other molecules (TNF receptors, Baker and Reddy, 1996), release of 
attached proteins (seven-transmembrane domain receptors, Casey and Gilman, 1988). 
The most frequent signalling molecules are kinases which phosphorylate either 
tyrosine or serine/threonine residues. Tyrosine- and serine/threonine kinases can 
phosphorylate the next kinase in a signalling cascade or other proteins and alter 
thereby the structure and activity of these proteins. Tyrosine phosphatases and 
serine/threonine phosphatases are the counterparts of the kinases; they 
dephosphorylate proteins (Hunter, 1995). 
A more detailed discussion of the importance of phosphorylation/dephosphorylation 
events and the structure of protein kinases will be given in the next sections. 
Heterotrimeric G-proteins are the proteins associated with seven-transmembrane 
domain receptors. The Gα as well as the Gβγ subunits transduce signals. The Gα-
subunit has GTPase activity. It its GTP-bound state it is turned on and interact with 
other proteins to transduce the signal, as soon as GTP is hydrolysed to GDP the Gα-
subunit is turned off, this means it no longer interacts with the other molecule to 
transduce the signal. The Gα-subunit also interacts with proteins that modulate its 
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activity (GTPase activating proteins, guanine-nucleotide exchange factors) (Neer, 
1995). 
Monomeric GTPases are similar to the Gα-subunit of heterotrimeric G-proteins; they 
bind in the GTP-bound state to its effector molecules as well (Hall, 1992). 
The hydrolysis of membrane constituents can generate second messengers. 
Phospholipases hydrolyse phospholipids. Phospholipase C hydrolyses 
phosphatidylinositol-3,4-bisphosphate and thereby generates the second messengers 
(second messengers are small diffusible molecules generated intracellularly in 
response to extracellular stimuli) diacylglycerol (which activates PKC) and 
inositoltrisphosphate (which induce a elevation of the intracellular Ca2+- level). PLC’s 
are regulated by heterotrimeric G-proteins (PLCβ‘s) or by receptor tyrosine kinases 
(PLCγ) (Kapeller and Cantley, 1994). PLD hydrolyses phosphatidylcholine to 
phosphatidic acid (PA) and choline. PLA2 converts PA to lysophosphatidic acid 
(LPA). PA and LPA can serve as second messengers (Liscovitch et al, 2000). 
Sphingomyelinases hydrolyse sphingolipids to ceramide and phosphatidylcholine. 
Ceramide serves as a second messenger (Ohanion and Ohanion, 2001). 
Phosphatidyinositol kinases phosphorylate the inositol ring of phosphoinosits at the 
D3 (PI-3-kinase) D4 (PI4-kinase) or D5 (PI5-kinase) position. PI-4 and PI-5 kinase is 
required to generate PtdIns-4-5- P2, the substrate of PLC. The products of PI-3 kinase, 
Ptd-3-4-P2, Ptd-3,4,5-P3 act as second messengers (Kapeller and Cantley, 1994). 
Several other kinases with similarity to PI-3 kinase are known, and some of them 
have, like PI-3 kinase, both lipid and protein kinase activity (Hunter, 1995). 
Phosphatidylinositol phosphatases are the counterparts of the phosphatidylinositol 
kinases (Myers et al, 1998). 
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Adaptor proteins have no enzymatic activity; they serve to bring other signalling 
molecules in close proximity to each other. The localisation of a signalling molecule is 
usually important for its activation (Pawson and Scott, 1997).  
cAMP and cGMP are second messengers. The levels of them are regulated by 
adenyl/guanyl cyclases (regulated by G-protein coupled receptors, and the guanyl 
cyclases also by nitric oxide) and cAMP/cGMP phosphodiesterases (Conti and Jin, 
1999; Schlossmann et al, 2003). These second messengers activate the protein kinases 
PKA and PKG, respectively. 
 
 
3.2.  Protein phosphorylation: 
Proteins get phosphorylated by the transfer of the γ-phosphate group of 
adenosintrisphosphate to the hydroxylgroup of tyrosine, serine or threonine. This 
reaction is catalysed by two groups of enzymes, tyrosine kinases, which catalyse the 
phosphorylation of tyrosine residues, and serine/threonine kinases, which catalyse the 
phosphorylation of serine and threonine residues (Krebs, 1983). As an exception, there 
are also dual specific kinases known which can phosphorylate all three residues 
(Becker and Joost, 1999) Tyrosine and serine / threonine kinases show a high degree 
of similarity, they seem to have evolved by divergent evolution. Phosphorylation is a 
reversible reaction. Protein phosphatases catalyse the hydrolysis of a phosphate group 
from either tyrosine or serine/threonine residues (as a exception, also dual specific 
phosphatases exist.) (Tonks and Charbonneau, 1989; Wera and Hemmings, 1995). 
Tyrosine and serine/threonine phosphatases have a low degree of similarity in their 
primary structure; they seem to have evolved by convergent evolution. 
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The phosphorylation/dephosphorylation of an amino acid residue can alter the 
conformation and thereby the function of a protein. The phosphorylation state of a 
protein is first of all dependent on the activity of the kinases and phosphatases that are 
targeted against the phosphorylation sites of the protein. 
 
3.3. Classification of protein kinases 
The human genome contains 518 kinase gens. Protein kinases are classified by 
similarities of their catalytic domains in seven main groups. (Manning et al, 2002): 
The AGC (containing PKA, PKG and PKC families) group, the CAMK 
(calcium/calmodulin-dependent protein kinase) group, the STE (homologs of yeast 
Sterile 7, Sterile 11 and Sterile 20 kinases) group, the CMGC (containing CDK, 
MAPK, GSK3 and CLK families) group, the CK1 (Casein kinase 1) group, the TKL 
(Tyrosine kinase like) group and the TK (Tyrosine kinase) group. Most kinases fall 
into one of these major groups. Closely related kinases form kinase families, like the 
NDR family, which consists of NDR1, NDR2, LATS1 and LATS2. Some kinases 
have little or no sequence similarity to the kinase superfamily. These kinases are 
atypical protein kinases, for example DNAPK. 
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3.4.  Structure of protein kinases 
The primary structures of the catalytic domains of all kinases show a high degree of 
similarities to each other. This indicates that almost all protein kinases have a common 
ancestor and was evolved by divergent evolution. Because of the similar primary 
structure, it is expected that the overall three-dimensional structures of all kinase 
catalytic domains are similar. By X-ray crystallographie, it was confirmed that the 
overall three-dimensional structures of the kinase catalytic domains are similar (Hanks 
and Hunter, 1995). The structure of the catalytic domain of PKA as a model for 
serine/threonine kinases is discussed below: 
The catalytic domain of PKA is built of two lobes. The catalytic site lies in the cleft 
between these two lobes. The smaller, N-terminal lobe (containing subdomains I-IV) 
forms a five-stranded antiparallel beta-sheet. This lobe is responsible for the binding 
of Mg-ATP. The larger, C-terminal lobe (subdomains V-XI) consists mainly of alpha 
helices. This lobe is responsible for substrate binding and catalysis. 
The catalytic domains of kinases can be further divided into twelve subdomains. The 
subdomains contain small regions with higher homology. The structural and functional 
features of the subdomains are the following: 
 
Subdomain I: 
Subdomain I contains a beta strand-turn-beta strand motif. The turn consists of the 
consensus motif: Gly-X-Gly-X-X-Gly-X-Val, named the glycine rich loop. The beta 
strands cover the alpha- and beta phosphates of ATP, while the glycine rich loop helps 
to anchor ATP to the protein. 
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Subdomain II: 
Subdomain II consists of a beta sheet with a small alpha helix towards the end. The 
residue Lys-72 in the consensus motif, AXK, is conserved in all kinases. This 
subdomain is important for kinase activity by interacting with the alpha and beta 
phosphates of ATP. 
 
Subdomain III: 
Subdomain III consists of a large alpha helix. The residue Glu-91 is invariant, this 
residue helps to stabilise the interaction between Lys-72 and the alpha and beta 
phosphates of ATP. 
 
Subdomain IV: 
Subdomain IV is a beta beta strand and contains no invariant residues. 
 
Subdomain V: 
This subdomain consists of a hydrophobic beta strand in the small lobe and a small 
alpha helix in the large lobe connected by a chain between them. The chain contains 
the residues Glu-121, Val-123 and Glu-127, which help to anchor Mg-ATP. Met-120, 
Tyr-122, Val-123 contribute to a hydrophobic pocket that surround the adenine ring of 
ATP. Glu-127 is in PKA important for substrate recognition. 
 
Subdomain VIA: 
Subdomain VIA is a large hydrophobic alpha helix with no invariant residues. 
 
Subdomain VIB: 
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Subdomain VIB consists of two small hydrophobic beta strands and a loop between 
them. The loop contains the invariant residues Asp-166 and Asn-171 within the 
consensus motif: D-X-K-X-X-N. This loop is known as the catalytic loop of the 
kinase. The residue Asp-166 is the catalytic base of the enzyme, the acceptor of the 
proton from the hydroxyl group of the serine or threonine from the substrate. Lys-168 
is important for the neutralisation of the local negative charge of the gamma-phosphate 
(This residue is usually replaced by arginine or alanine in tyrosine kinases). Asn-171 
assists in the stabilisation of the catalytic loop and chelates Mg2+, while Glu-170 is 
important for the stabilisation of the binding of ATP and the substrate in PKA. 
 
Subdomain VII: 
This subdomain consists of a beta strand-loop-beta strand. It contains the consensus 
motif Asp-Phe-Gly (DFG). Asp-184 is important for the orientation of the gamma-
phosphate of ATP by chelating the Mg2+ that bridges the beta and gamma phosphate 
of ATP. 
 
Subdomain VIII: 
Subdomain VIII is a chain, which faces the cleft between the large and small lobe. 
This chain contains the consensus motif Ala-Pro-Glu (APE). Glu-208 stabilises the 
large lobe. This subdomain is important for substrate recognition. In PKA, Leu-198, 
Cys-199, Pro-202 and Leu-205 contibute to a hydrophobic pocket that protects the 
side chain of the hydrophobic residue at position +1 in the substrate consensus 
sequence of PKA (RRXSY, Y is a hydrophobic amino acid). Subdomain VIII contains 
the activation (or T-) loop. Many kinases are activated by phosphorylation of 
threonine or serine in this loop (Thr-197 in PKA).  
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Subdomain IX: 
Subdomain IX is a large alpha helix. This helix is important for the structure of the 
kinase as well as for substrate recognition. Invariant Asp-220, this residue helps to 
stabilise the catalytic loop in subdomain VIA. 
 
Subdomain X: 
This subdomain is a small alpha helix with no invariant residues. 
 
Subdomain XI: 
Subdomain XI is build of a helix-loop-helix motif. Nearly invariant is the residue Arg-
280. 9 to 13 residues down of the invariant Arg is the consensus motif His-X-aromatic 
amino acid-hydrophobic amino acid. 
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3.5.  Regulation of serine/threonine kinases 
3.5.1.  Phosphorylation/dephosphorylation 
Generally, kinases are regulated by phosphorylation and dephosphorylation of certain 
threonine/serine and tyrosine residues. Phosphorylation alters the conformation of the 
kinases and thereby their activity. Phosphorylation can increase or decrease the kinase 
activity of a kinase. In many kinases, an activating phosphorylation site has been 
mapped to the T-loop. Regulatory phosphorylation sites have also been mapped at 
other sites in the catalytic domain and in the carboxy-terminal regulatory domain. 
(Russo et al, 1996; Yang et al, 2002) 
Some sites can be constitutively phosphorylated; others change their phosphorylation 
state. In some kinases, sites that are phosphorylation sites in other kinases are replaced 
with acidic residues (aspartate, glutamate), which have a similar negative charge as 
phosphate groups (Johnson et al, 1996). . The phosphorylation state of a kinase is 
determined by the activity of kinases (upstream kinases or the kinase which 
autophosphosphorylates itself) and phosphatases. 
 
 
3.5.2.  Subcellular localisation 
The in vitro substrate specificity of different kinases often overlaps. So the question 
rises how these kinases can elicit their different functions. An important aspect in this 
context is the localisation of a kinase.  
In the cell, the activity is also determined by the localisation of a kinase. Kinases have 
to localise in close proximity to their upstream regulators, for example to receptors or 
other membrane associated proteins. The modulation of the kinase by this proteins can 
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then in turn, a part from the alteration of the activity, induce the translocation of the 
kinase to another subcellular compartment.  
The exact localisation of kinases then determines (a part from the substrate specificity) 
which substrates the kinase can phosphorylate (Griffioen and Thevelein, 2002). 
Kinases often form complexes with their modulators and substrates. 
 
3.5.3.  Protein-protein interactions 
Kinases are not only regulated by phosporylation, often they are regulated by 
interaction with regulatory subunits. The binding of another protein can induce a 
conformational change of the kinase and thereby activate or inactivate it. The 
expression levels of the regulatory subunit can in these cases regulate the kinase 
activity, or the concentration of a low molecular weight ligand, for example GTP or 
second messengers like Ca2+, which bind to the regulatory protein and thereby alters 
the interactivity of it with the kinase. 
 
 
3.5.4.  Second messengers 
Second messengers are small diffusible molecules that are generated intracellularly in 
response to extracellular stimuli. Second messengers regulate the activity of kinases. 
Four main mechanisms are known: 
 -Inducing the dissociation of an inhibitory subunit from a kinase catalytic 
domain, e.g. PKA, cAMP as second messenger (McKnight, 1991). 
 -Second messenger dependent association of an activating subunit with the 
kinase catalytic domain, e.g. CaM kinases, Ca2+ as second messenger (Nairn, 1990). 
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 -Direct binding of the second messenger to the kinase e.g. PKC, Ca2+ and 
diacylglycerol as second messsengers (Ron and Kazanietz, 1999). 
 -Second messenger induced delocalisation, e.g. localisation of PKB by Ptd 
Ins3,4-bisphosphate to the membrane (Meier and Hemmings, 1999). 
Some soluble low molecular weight regulatory molecules are not produced in response 
to extracellular stimuli, e.g. AMP that signals the metabolic state of the cell (Hardie et 
al, 1998). 
The diverse regulatory mechanisms (phosphorylation, regulation of the subcellular 
localisation, protein-protein interactions and second messengers) can act together to 
regulate a kinase. 
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4. NDR serine/threonine kinase 
The NDR (nuclear-Dbf2-related) kinase was cloned from human fetal brain, D. 
melanogaster and C. elegans (Millward et al, 1995). NDR kinase belongs to a highly 
conserved family of kinases, a subclass of the AGC-family of kinases (Manning et al, 
2002). The NDR family of kinases includes mammalian protein kinases NDR1 and 
NDR2, Drosophila melanogaster NDR/TRC, Caenorhabditis elegans Sax1, 
mammalian, D. melanogaster and C. elegans large tumour suppressor (LATS) kinases, 
Neurospora Cot1, Ustilago maydis UKC1, Saccharomyces cerevisiae Cbk1, Dbf2 and 
Dbf20, Schizosaccharomyces pombe Orb6 and Sid2 and a number of plant kinases 
(Tamaskovic et al, 2003). 
 
4.1. Structure of human NDR kinase 
The NDR serine/threonine kinase amino acid sequence shows all the twelve 
subdomains of the kinase catalytic domain (Hanks and Hunter, 1995). NDR kinases 
are most closely related to members of the AGC-group of serine/threonine kinases. 
However, the catalytic domain of NDR is interrupted by an insertion of about 30 
amino acids between subdomain VII and VIII. This insertion into the catalytic domain 
is a special feature of NDR family kinases. The insertion is situated just in front of the 
phosphorylation site in the activation loop. The N-terminal regulatory domain is 
another characteristic region of NDR family kinases. This domain is highly conserved 
among NDR family kinases. It was shown that a region within this domain could bind 
directly to S100-Ca2+ binding proteins (Millward et al, 1998, Bhattacharya et al, 
2003). Finally, the C-terminal extension contains a broadly conserved hydrophobic 
motif that is an important regulatory element within the AGC group of protein kinases 
(Yang et al, 1999). 
 21 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.2. Relatives of NDR 
4.2.1. NDR is related to members of the AGC-group of kinases 
NDR is related to members of the AGC-group, like PKA, PKB, PKG, PKCs, PRK, 
p70-S6 kinase, p90RSK, SGK and PDK1. Typically, AGC kinases have in common the 
position of the important phosphorylation site in the activation loop and the one in the 
C-terminal regulatory domain, the hydrophobic motif site.  
 
4.2.2. NDR family kinases 
NDR is closely related to kinases found throughout the eukaryotic world (animals, 
plants and fungi). The NDR related kinases constitute a kinase family, the NDR family 
of kinases. These kinases all show a high conservation of at least a part of the N-
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terminal domain, an interruption of the kinase catalytic domain between subdomains 
VII and VIII, and a conservation of the regions surrounding the regulatory 
phosphorylation sites. The members of the NDR family are more distantly related to 
other kinases such as the Ghengis Khan (GEK) kinases, DMPK and MRCK, the 
ROCK kinase and the budding yeast kinase RIM15. The function of NDR kinases has 
been conserved over long evolutionary distances, mainly involving various aspects of 
cell division and morphogenesis. 
 
4.2.2.1 Saccharomyces cerevisiae Cbk1 
Cbk1 is the closest relative of NDR in S. cerevisiae with an identity of the catalytic 
domain of 59%. Cbk1 mutants show large aggregates of unseparated cells, the cells 
are round instead of ellipsoidal, the apical growth is diminished and the budding 
pattern is random instead of bipolar. (Racki et al. 2000; Bidlingmaier et al, 2001). The 
localisation of Cbk1 is cell cycle dependent. During bud and mating projection 
formation, Cbk1 localises to sites of polarised growth and cell wall remodelling, such 
as the actively expanding cell cortex. During mitotic exit, Cbk1 moves to the bud neck 
and to the daughter cell nucleus. The localisation as well as the kinase activity of Cbk1 
was shown to be dependent on several proteins that form a novel regulatory network. 
This network is, on the one hand, responsible for the daughter cell specific nuclear 
localisation of the transcription factor Ace2p, which controls the expression of genes 
important for the degradation of the septum, such as scw11 and cts1 encoding 
glucanase and chitinase. On the other hand, Cbk1 is important for polarised apical 
growth and mating projection formation, these functions are independent of the Ace2 
transcription factor. The regulatory network that is controlling these two functions has 
been described as the RAM network (Regulation of Ace2p activity and cellular 
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morphogenesis). The RAM consists of Cbk1, Mob2, a small activator of NDR kinases, 
Tao3, a 270 kda protein of unknown molecular function, Hym1, a relative of human 
MO25, the Ste20 like kinase Kic1 and the leucine-rich repeat containing protein Sog2. 
All the components are required for Cbk1 kinase activity. The localization to the 
daughter nucleus of Cbk1-Mob2 depend on all other components of the RAM-network 
and all RAM components localize to sites of polarized growth and interact physically 
(Nelson et al, 2003). The components of the RAM network are conserved throughout 
the eukaryotic world. 
 
4.2.2.2. Schizosaccharomyces pombe Orb6 
Orb6 is the closest relative of NDR in S. pombe; its catalytic domain is 58 % identical 
to NDR. Orb6 was originally identified as one of 12 orb gens involved in cell 
morphogenesis (Verde et al, 1995). S. pombe cells switch in the early G2 phase to 
bipolar growth. The cells grow at the new tip that was formed by cell division (new 
end take off, NETO). The bipolar growth continues until mitosis. During these cell 
cycle transitions, profound changes in the actin cytoskeleton occur, involving 
formation of distinct actin patches at the growing tips in interphase and the actin ring 
during mitosis. Orb6 mutants loose growth polarity and become spherical, 
microtubules are disorganised and actin dots delocalised. Furthermore, Orb6 mutants 
enter mitosis earlier. On the other hand, an increase of the Orb6 levels delays mitosis 
and maintains cell polarity. Taken together, Orb6 is required to maintain cell polarity 
during interphase and to promote actin reorganisation after mitosis and during 
activation of bipolar growth.  
Furthermore, Orb6 influences cell cycle progression by delaying the onset of mitosis. 
This delay is dependent on Orb6 kinase activity, and Orb6 affects the Cdc2 mitotic 
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kinase (Verde et al, 1999). The localisation of Orb6 protein changes during the cell 
cycle. During interphase, it is localised at the cell tips and during mitosis and 
cytokinesis at the region of the developing septum, which is consistent with a role of 
this kinase in polarised growth and cell division (Verde et al, 1999). Orb6 interact 
physically and genetically with the Furry-like protein Mor2/Cps12 and the S.pombe 
Mob2 protein (Hirata et al, 2002; Hou et al, 2003). 
 
4.2.2.3. Saccharomyces cerevisiae Dbf2 and Dbf20 
Dbf2 and Dbf20 are the second closest relatives of NDR kinase. Its catalytic domains 
are 40% identical to human NDR kinase. Temperature sensitive Dbf2 mutants arrest at 
restrictive temperature at the end of anaphase with large budded “dumbbell” 
morphology, and their mitotic spindles are elongated which is indicative of incomplete 
nuclear division (Johnston et al, 1990). The kinase activity of Dbf2 is cell cycle 
dependent, with a maximal activity in anaphase, when Dbf2 is localised to spindle 
pole bodies (SPB or yeast centrosomes) (Toyn and Johnston, 1994; Visintin and 
Amon, 2001). The localisation of Dbf2 changes later in mitosis, it moves to the bud 
neck prior to actin medial assembly, consistent with the role of Dbf2 in cytokinesis 
(Frenz et al, 2000). Dbf2 is part of a network described as the MEN (mitotic exit 
network). The MEN is important for the inactivation of mitotic cyclin dependent 
kinases and for the completion of cytokinesis. (Bardin and Amon, 2001). The mitotic 
exit network consists of the GTPase Tem1 and its exchange factor Lte1 (Shyrayama et 
al, 1994), the polo like kinase Cdc5 (Kitada et al, 1993), the Ste20 like kinase Cdc15 
(Surana et al), Dbf2 and Dbf20 (Toyn and Johnston, 1994), the protein phosphatase 
Cdc14 (Visintin et al, 1998), and Mob1 (Komarnitsky et al, 1998). The MEN is 
inhibited by the Bub2 dependent spindle checkpoint (Fesquet et al, 1999). The MEN 
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gets activated after sister chromatid separation is completed. Tem1 binds to its 
exchange factor Lte1, probably enabled by the transport of the Tem1 carrying spindle 
pole body (SPB) to the daughter cell, where Tem1 is then in close proximity to Lte1. 
This leads to localization of Cdc15 to this SPB (Asakawa et al 2001), and activation of 
the NDR family kinase Dbf2 that is bound to Mob1 (Mah et al, 2001). Activation of 
the MEN finally leads to the release of the protein phosphatase Cdc14 from the 
nucleolus (Shou et al, 1999), which then triggers mitotic exit by dephosphorylation of 
Hct1 and Sic1 (Visintin et al, 1998). Dephosphorylated Hct1 binds to the anaphase 
promoting complex APC, an ubiquitin ligase. The APC-Hct1 complex leads to the 
destruction of mitotic cyclins, thereby inactivating Cdk (Zachariae et al, 1998). Sic1 is 
a Cdk inhibitor, and Swi5 is a transcription factor responsible for Sic1 expression. 
Sic1 as well as Swi5 are activated by dephosporylation (Visentin et al, 1998; Toyn et 
al, 1997; Verma et al, 1997). Furthermore, the polo like kinase Cdc5 acts in a complex 
way on MEN signalling: On the one hand, Cdc5 is required for Dbf2 activity, on the 
other hand, Cdc5 negatively regulate MEN signalling, acting upstream of Tem1 (Lee 
et al, 2001). 
In addition to mitotic exit, MEN proteins are also directly involved in cytokinesis. It 
was shown that mob1 mutants displayed cytokinesis defects even under conditions 
where mitotic exit was not disturbed. In these mutants, the contractile ring at the bud 
neck was present, but the ring failed to contract and disassemble (Luca and Winey, 
1998).  
 
4.2.2.4. Schizosaccharomyces pombe Sid2 
Sid2 is the S. pombe homologe of Dbf2. Its catalytic domain is 39% identical to that of 
human NDR kinase. Sid2 mutants are defective in septum formation during 
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cytokinesis (Balasubramanian et al, 1998; Sparks et al, 1999). Sid2 function in the SIN 
(Septation Initiation Network), a network that coordinates late mitotic events with 
cytokinesis (Mc Collum and Gould, 2001; Bardin and Amon, 2001). The SIN consists, 
a part from Sid2, of the small kinase activator protein Mob1 (Salimova et al, 2000), 
the GTPase Spg1 (Schmidt et al, 1997), the GTPase activating proteins (GAP) Cdc16-
Byr4, which negatively regulate the SIN (Iwa and Song, 1998; Furge et al, 1998), the 
Polo like kinase Plo1 (Ohkura et al, 1995), the Ste20-like kinases Cdc7 (Fankhauser 
and Simanis, 1994) and Sid1 with its activating subunit Cdc14 (Fankhauser and 
Simanis, 1993; Guertin et al, 2000), the phosphatase Clp1 (Trautmann et al, 2001), and 
the scaffold proteins Cdc11 (Marks et al, 1992) and Sid4 (Balasubramanian et al, 
1998). The SIN is required for actomyosin ring constriction and septum formation 
after chromosome separation is completed. The SIN proteins localize to the spindle 
pole body, where Sid2-gets activated when sister chromatide separation is completed. 
The activated Sid2-Mob1 complex translocates to the actomyosin ring prior to cell 
separation (Sparks et al, 1999). 
 
4.2.2.5. Fungal kinases Cot1/Ukc1/Tb3 
Neurospora crassa Cot1, Ustilago maydis Ukc1 and Colleotrichum trifolii TB3 have 
an identity of their catalytic domains of about 50% to human NDR, and the regulatory 
domains are well conserved. N. crassa, U. maydis and C. trifolli are filamentous fungi 
that grow by apical extensions of their hyphal tips. The hyphae branch and form a new 
growing tip after elongation. In Cot1 mutants, the elongation of the hyphaes is 
prevented and the hyphaes branch more frequent, therefore Cot1 mutants grow slower 
and form compact colonies (Yarden et al, 1992). C. trifolii TB3 can complement N. 
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crassa Cot1 mutants (Buhr et al, 1996). Ukc1 mutants are not able to generate aerial 
filaments during mating (Duerrenberger and Kronstad, 1999). 
 
 
4.2.2.6. Plant NDR family kinases 
Several NDR family kinases were identified in plant genomes, but their function was 
not yet described.  
 
4.2.2.6. Protozoan protein kinases 
In Protozoans, NDR is conserved in Trypanosoma species, but not in other clinical 
relevant species like Plasmodia. NDR related kinases were also discovered in Euplotes 
(Tan et al, 2001). 
 
4.2.2.7. LATS kinases in mammalians and Drosophila 
Drosophila and human LATS (Large tumour suppressor) kinase posses a catalytic 
domain which is about 55% identical to human NDR, but the regulatory important 
regions of NDR (phosphorylation sites, N-terminal domain) are less conserved than in 
the other NDR family kinases. The N-terminal domain of NDR is longer than that of 
NDR, and it contains glutamine and proline rich (Drosophila LATS) or proline rich 
(human LATS) stretches. In these respects, the LATS kinases are similar to Cbk1 and 
the fungal kinases Cot1, Ukc1 and TB3.  
Drosophila LATS/Wts mutants were isolated in a mosaic screen designated to 
discover overproliferation mutations that are lethal at early developmental stages 
(Justice et al, 1995; Xu et al, 1995). Therefore, mitotic recombination in somatic cells 
was induced and thereby chimaeric animals with clones of mutated cells were 
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obtained. Clones of homozygous Lats mutant cells overproliferate and produce 
spectacular outgrowths. Clones of Lats mutants are round or spherical shaped, so the 
cells of the imaginal discs have not divided oriented as in the case of wild type 
imaginal discs. Furthermore, Lats mutant cells have an altered cell shape. Taken 
together, loss of LATS/Wts function is lethal during development and causes in 
genetic mosaic clones overproliferation, disoriented cell divisions and a change of the 
cell morphology. In humans exist two close relatives of Drosophila LATS/Wts, 
hLATS1 and hLATS2/Kpm. LATS1 kinase affects cell proliferation. Transduction of 
LATS1 into many tumor cell lines induces an inhibition of cell proliferation, and 
ectopic expression of LATS1 specifically reduces the cyclin A and cyclin B protein 
levels and thereby induces a reduction of CDK1 activity, which leads to growth arrest 
in the G2/M phase. It can also promote apoptosis by the induction of the Bax protein 
level (Xia et al, 2002, Yang et al, 2001). Furthermore, LATS1 was reported to affect 
cytokinesis by the inhibition of LIMK1 (Yang et al, 2004). Human LATS1 is 
phosphorylated in a cell cycle dependent manner; it is phosporylated at late prophase 
and throughout metaphase and gets dephosphorylated at anaphase. It was reported that 
LATS1 interacts directly with CDC2 in early mitosis when LATS1 is phosphorylated, 
and thereby inhibits CDC2 activity directly (Tao et al, 1999). LATS1 localises to the 
centrosomes during interphase, translocates to the mitotic spindle during metaphase 
and anaphase and to the midbody in telophase (Nishiyama et al, 1999). Mouse LATS 
knock out mice displayed impaired mammary gland development, infertility, growth 
retardation and the development of soft tissue sarcomas and ovarian stromal cell 
tumors (St. John et al, 1999). Taken together, LATS1 acts as a tumor suppressor by 
negatively regulating cell proliferation and by modulating cell survival. Human 
LATS2 kinase, an isoform of LATS1 kinase, negativly regulates cell growth by 
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inducing G2/M arrest and apoptosis as well (Kamikubo et al, 2003). LATS2 kinase 
localises to centrosomes and is a phosphorylation target of Aurora-A kinase (Toji et al, 
2004). 
 
 
4.3. Localisation of NDR kinase 
Human NDR1, which was overexpressed in COS-1 cells, was detected in the nucleus. 
(Millward et al, 1995). By further localisation studies it was shown that NDR is not 
primarily localised to the nucleus but rather also to membranes and the cytosol, and 
endogenous NDR phosphorylated on threonine 444 was localised to membranes and 
the cytosol (Bichsel, unpublished, see figure; Hergovich et al, manuscript in 
preparation).  
A)                                     B) 
 
 
 
Localisation of Thr-444 phosphorylated, endogenous NDR in COS-1 cells. A) 
Localisation with anti-P-Thr-444 antibody.  B) Control, competition with antigen 
(T444-phosphopeptide). 
 
4.4. Regulation of NDR kinase by phosphorylation: 
While there is no physiological upstream signal known to stimulate NDR kinase 
activity, NDR1 and NDR2 is potently activated in vivo by treatment with the PP2A-
inhibitor okadaic acid. Okadaic acid treatment of COS-1 cells leads to phosphorylation 
of the activation segment site Ser-281/Ser-282 and the hydrophobic motif site Thr-
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444/Thr-442 (Millward et al, 1999; Stegert et al, 2004). These sites are also important 
regulatory phosphorylation sites in other kinases of the AGC group (Parker and 
Parkinson, 2001). It was shown for the prototypical AGC kinase PKA that he 
activation segment residue aligns in its phosphorylated form the catalytic site of this 
kinase, thereby generating an active kinase conformation (Knighton et al, 1991). The 
structure of PKBβ confirmed this role of the activation segment residue and defined 
the function for the hydrophobic motif. The hydrophobic motif site, upon 
phosphorylation, undergoes a series of interactions with αB- and αC-helices of the 
catalytic domain, thereby promoting disorder to order transition of this part of the 
molecule. This transitions leads to restructering of the activation segment and 
reconfiguration of the kinase bilobal structure (Yang et al, 2002).  
The activation segment site is an autophosphorylation site in vivo. Kinase inactive 
NDR becomes not phosphorylated at that position, the kinase activity of NDR is 
required for the phosphorylation of the activation segment (Tamaskovic et al, 2003). 
In most other AGC kinases, including PKB, p70S6K, SGK, p90RSK and PKC isoforms, 
however, the activation segment site is phosphorylated by phosphoinositide dependent 
kinase PDK1 (Belham et al, 1999). Some AGC kinases become phosphorylated in 
absence of PDK1 (PKA, PKCδ, AMPK, MSK1 and PRK2) (Williams et al, 2000; 
Balendran et al, 2000). NDR is not phosphorylated by PDK1, neither in vivo nor in 
vitro (Millward et al, 1999). This may be due to the fact that the NDR sequence 
surrounding the activation segment site is different in the P+1 and P+2 position to the 
highly conserved PDK1 consensus target site (Ser/Thr-Phe-Cys-Gly-Thr-Xaa-
Asp/Glu-Tyr-Xaa-Ala-Pro-Glu, where Ser/Thr is the phosphoacceptor site and Xaa 
stands for a hydrophobic residue). Taken together, NDR is not targeted by PDK1 but it 
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becomes efficiently autophosphorylated at the activation segment residue both in vivo 
and in vitro.  
Kinase inactive NDR become phosporylated on the hydrophobic motif 
phosphorylation site to the same extend as wild type NDR in vivo. Thus, NDR 
becomes phosphorylated by an upstream kinase. The hydrophobic motif 
phosphorylation site is conserved amongst almost all AGC group kinases. The 
hydrophobic motif site of NDR is phosphorylated by the Ste20 like kinase MST3 
(Stegert et al, manuscript in preparation). The S. cerevisiae NDR relative Dbf2 was 
shown to become phosphorylated by the Ste20 like kinase Cdc15 (Mah et al, 2001), 
and Kic1, a close relative of MST3, is part of the Cbk1 involving RAM-network 
(Nelson et al, 2003). Furthermore, in S.pombe, the Ste20 like kinase Sid1 is placed 
upstream of the NDR relative Sid2 (Guertin et al, 2000), and Pak1 genetically interacts 
with Orb6 (Verde et al, 1998). Taken together, Ste20 like kinases are likely to 
accomplish the role to phosphorylate the hydrophobic motif of NDR kinases. The 
hydrophobic motifs of other AGC group kinases are likely to be phosphorylated by 
different kinases. For PKB, it was shown that DNA-dependent kinase (DNA-PK) acts 
as one of the hydrophobic motif upstream kinases (Feng et al, 2004).  
Ca2+ is required for NDR kinase activation in vivo, depletion of Ca2+ by the 
intracellular Ca2+-Chelator BAPTA-AM leads to reduced phosphorylation of the 
activation segment- as well as of the hydrophobic motif phosphorylation sites. Ca2+-
bound S100B binds to an amphiphilic helical region of the N-terminal domain of 
NDR, and S100B binding increases NDR autophosphorylation as well as 
transphosphorylation activity in vitro. (Millward et al, 1998; Tamaskovic et al, 2003; 
Stegert et al, 2004). NDR kinase is activated in a number of S100B overexpressing 
melanoma cell lines (Millward et al, 1998). Given the facts that S100B is bound to 
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OA-stimulated and unstimulated NDR and that an increase of the Ca2+ level by 
treatment with calcium ionophores induces only a slight activation, Ca2+/S100B may 
be necessary, but not sufficient, for NDR activation to occur in vivo. 
 
 
4.5. Expression of NDR1 and NDR2 kinase 
In mammalians, two NDR isoforms exist, NDR1 and NDR2. There seem to be no 
obvious differences regarding the posttranslational regulation of these two kinases, but 
they differ in their tissue specific distribution. By TaqMan real-time PCR analysis, the 
highest expression levels of mNdr1 were observed in spleen, lung, thymus, brain, and 
fat tissue, whereas mNdr2 expression was found mainly in the large and small 
intestine, as well as in the stomach and testis. Assuming similar PCR efficiency for 
both reactions, mNdr2 appears to be the predominantly expressed isoform in mice. 
These data suggest tissue-specific functions of NDR1 and NDR2 in mammals (Stegert 
et al, 2004). 
 
4.6. Substrates of NDR kinases 
To date, no physiological substrate, neither of NDR kinase nor of one of the other 
NDR family kinases, has been discovered. NDR is able to efficiently phosphorylate a 
synthetic peptide with the sequence KKRNRRLSVA (Millward et al, 1998). 
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Abstract: 
Serine/threonine kinases of the nuclear Dbf2-related (NDR) family are highly 
conserved throughout the eukaryotic world. Members of this kinase family are 
implicated in various aspects of the regulation of cell division and cell morphology. It 
has been shown that the function of several NDR kinases is dependent on proteins of 
the Mob (MPS one binder) family. Mob proteins are highly conserved as well, and in 
humans they constitute a group of seven related proteins. In the last couple of years, it 
turned out that Mob proteins act as kinase activating subunits for NDR family kinases, 
similar to the role cyclins are playing in activating cyclin dependent kinases (Cdks). 
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1. Introduction 
NDR (nuclear Dbf2-related) kinases constitute a family within the AGC group of 
serine/threonine kinases (1). They all contain the 12 subdomains of the kinase catalytic 
domain as described by Hanks and Hunter (2). However, the NDR kinase structure 
possesses unique features: First, their catalytic domain is interrupted by an insertion of 
about 30-60 amino acids between subdomains VII-VIII. Second, the N-terminal 
regulatory domain is unique and highly conserved among the NDR family of kinases. 
NDR family kinases are implicated in the regulation of cell division and cell 
morphology (3). 
In 1998, Komarnitzsky et al have shown that S. cerevisiae Mob1 interacts physically 
and genetically with Dbf2, a yeast NDR family kinase (4). S. cerevisiae Mob1 was 
shown before to be an essential gene required for the completion of mitosis and 
maintenance of ploidy (5). MOB proteins are highly conserved during evolution. In 
the last couple of years, it has been revealed that MOB proteins play an important role 
for the function of NDR family kinases. MOB proteins influence the function of NDR 
kinases in Saccharomyces cerevisiae, Schizosaccharomyces pombe and Homo sapiens. 
In this article, we review the current knowledge about the important role MOB 
proteins are playing in concert with kinases of the NDR family. 
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2. The MOB protein family 
 
MOB proteins constitute a protein family of highly conserved proteins; they are found 
in vertebrates, insects, worms, fungi, plants and protozoans with an identity of the 
amino acid sequences of at least 47 % (Fig.1). In humans, the MOB proteins diverged 
in at least six isoforms: hMOB1A and B, hMOB2, hMOB3A, B, and C. Furthermore, 
another protein termed “phocein” is also closely related to the MOB proteins (Fig.2). 
This divergence is conserved in other mammalian organisms, for example mice, which 
also possess MOB1, MOB2, MOB3 and phocein proteins, with an identity of the 
amino acid sequences between 92 and 100% to the respective human isoforms. 
Despite the high diversity of the MOB protein family in mammalians, there was no 
function known for these proteins until recently. MOB proteins also contain no known 
functional domains. The part of the amino acid sequence, which aligns well amongst 
all MOB family members (amino acids 29-213 of hMOB1A), is referred to as the 
Mob1_Phocein domain (Pfam accession nr. PF03637). 
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Fig.1: Alignement of the amino acid sequences of MOB proteins. 
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Fig. 2: Alignement of the amino acid sequences of human MOB proteins 
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3. Functions of MOB proteins in yeast: 
3.1. S. cerevisiae 
S. cerevisiae MOB1 was originally identified as an essential yeast gene (6) and in a 
yeast two-hybrid screen as an interactor with MPS1, a dual specificity protein kinase 
required for spindle pole body duplication and for the mitotic checkpoint (7). 
However, further studies have shown that Mob1 is responsible for different functions 
than Mps1 (5). Mob1 acts in the mitotic exit network (MEN) and in the control of 
cytokinesis (8). The mitotic exit network consists of the GTPase Tem1 and its 
exchange factor Lte1 (9), the polo like kinase Cdc5 (10), the Ste20 like kinase Cdc15 
(11), the Ndr-family kinases Dbf2 and Dbf20 (12), the protein phosphatase Cdc14 (13) 
and Mob1 (4). The MEN is inhibited by the Bub2 dependent spindle checkpoint (14). 
The MEN gets activated after sister chromatid separation is completed. Tem1 binds to 
its exchange factor Lte1, probably enabled by the transport of the Tem1 carrying 
spindle pole body (SPB) to the daughter cell, where Tem1 is then in close proximity to 
Lte1 (15). This leads to localization of Cdc15 to this SPB (16), and activation of the 
NDR family kinase Dbf2 that is bound to Mob1 (17). Activation of the MEN finally 
leads to the release of the protein phosphatase Cdc14 from the nucleolus (18), which 
then triggers mitotic exit by dephosphorylation of Hct1 and Sic1 (19). 
Dephosphorylated Hct1 binds to the anaphase promoting complex APC, an ubiquitin 
ligase. The APC-Hct1 complex leads to the destruction of mitotic cyclins, thereby 
inactivating Cdk (20). Sic1 is a Cdk inhibitor, and Swi5 is a transcription factor 
responsible for Sic1 expression. Sic1 as well as Swi5 are activated by 
dephosporylation (19,21,22 ). Furthermore, the polo like kinase Cdc5 acts in a 
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complex way on MEN signalling: On the one hand, Cdc5 is required for Dbf2 activity, 
on the other hand, Cdc5 negatively regulate MEN signalling, acting upstream of Tem1 
(23). 
In addition to mitotic exit, MEN proteins are also directly involved in cytokinesis. It 
was shown that mob1 mutants displayed cytokinesis defects even under conditions 
where mitotic exit was not disturbed. In these mutants, the contractile ring at the bud 
neck was present, but the ring failed to contract and disassemble (8). The MEN 
components Dbf2 and Mob1 are localized to the spindle pole body (SPB) during 
anaphase but subsequently move to the bud neck, consistent with their role in 
cytokinesis (24). The localization of Dbf2 and Mob1 is dependent on the activity of 
the protein phosphatase Cdc14, which is high when mitotic exit is completed (8,25). 
Taken together, Mob1 and the NDR family kinase Dbf2 are important components of 
signalling networks required for exit from mitosis and the completion of cytokinesis. 
Mob1 is required for the kinase activity of Dbf2 and binds directly to Dbf2 (4,23). In 
vitro, Mob1 and the Ste20-like kinase Cdc15 are sufficient to promote the 
phosphorylation of the activation segment site Ser-374 and the hydrophobic motif site 
Thr-544. Cdc15 alone does not efficiently phosphorylate Dbf2 (17).  
S. cerevisiae Mob2 is 90% identical to Mob1. Mob2 interacts with the NDR family 
kinase Cbk1 (26), the closest relative of human NDR kinase. Cbk1 has two different 
functions: it is important for the maintenance of polarized cell growth and is required 
for cell separation (27). Cell separation, the degradation of the septum after 
cytokinesis, requires the transcription of genes controlled by the Ace2 transcription 
factor (28. Cbk1 kinase activity is required for Ace2-dependent transcription. Mob2 is 
required for the kinase activity as well as for daughter-cell specific localisation of 
Cbk1 (29,30). The control of polarized growth, on the other hand, is Ace2-
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independent. During polarized growth, Cbk1 and Mob2 localise interdependently to 
the bud cortex, while they localize to the bud neck and the daughter nucleus late in 
mitosis. Cbk1 kinase activity is cell cycle dependent, the activity is high in G1, low 
after release from G1, high during budding and maximal late in the cell cycle when the 
cells are large budded, consistent with the role of Mob2-Cbk1 in mating projection 
formation and cell separation. The Cbk1-Mob2 network is connected to the MEN 
network, since signalling from the MEN is required for nuclear localization of Cbk1-
Mob2. (30). Other components of the network, which regulates Ace2 dependent 
transcription, and the maintenance of polarized growth were discovered. The RAM 
network (Regulation of Ace2p activity and cellular morphogenesis) consists of Cbk1, 
Mob2, Tao3, a 270 kda protein of unknown molecular function, Hym1, a relative of 
human MO25, the Ste20 like kinase Kic1 and the leucine-rich repeat containing 
protein Sog2. All the components are required for Cbk1 kinase activity. The 
localization to the daughter nucleus of Cbk1-Mob2 depends on all other components 
of the RAM-network and all RAM components localize to sites of polarized growth 
and interact physically (31). The components of the RAM network are conserved 
throughout the eukaryotic world.  
3.2. S. pombe: 
In S. pombe, the components of the MEN and RAM signalling networks are well 
conserved. S. pombe Mob1 is required for the initiation of medial ring constriction and 
septation. Mob1 localizes to spindle pole bodies throughout mitosis and to the cell 
division site later in mitosis. It interacts with the NDR family kinase Sid2, a close 
relative of S. cerevisiae Dbf2. Sid2-Mob function in the SIN (Septation Initiation 
Network), a network that coordinates late mitotic events with cytokinesis (32,33). The 
SIN consists, a part from Sid2 and Mob1, of the GTPase Spg1 (34), the GTPase 
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activating proteins (GAP) Cdc16-Byr4, which negatively regulate the SIN (35,36), the 
Polo like kinase Plo1 (37), the Ste20-like kinases Cdc7 (38) and Sid1 with its 
activating subunit Cdc14 (39, 40), the phosphatase Clp1 (41), and the scaffold proteins 
Cdc11 (42) and Sid4 (43). The SIN is required for actomyosin ring constriction and 
septum formation after chromosome separation is completed. The SIN proteins 
localize to the spindle pole body, where Sid2 gets activated when sister chromatide 
separation is completed. The activated Sid2-Mob1 complex translocates to the 
actomyosin ring prior to cell separation (44). For a detailed review of SIN and MEN 
signalling, see reviews (45-47). Mob1 is essential for Sid2 kinase activity and 
localization and binds directly to the N-terminal domain of Sid2 (48), a region that is 
highly conserved amongst NDR-family members. 
The serine/threonine kinase Orb6 is the closest relative of human NDR and budding 
yeast Cbk1 in S. pombe. Orb6 is important for maintaining the cell polarity and for the 
coordination of cell morphogenesis with the cell cycle. Reduction of the Orb6 level 
leads to loss of polarized cell shape and to mitotic advance, while overexpression of 
Orb6 delays mitosis by affecting the p34cdc2 mitotic kinase. The delay is dependent on 
Orb6 kinase activity. Orb6 localizes to the cell tips during interphase and to the 
division site during mitosis (49). Orb6 genetically interacts with the Tao3/Pag1 
relative Mor2/Cps12. Mutation of Mor2/Cps12 results in lost of cell polarity, the same 
phenotype as the Orb6 knock-down, and a G2 delay, as observed by Orb6 
overexpression (50). The methyltransferase Skb1, which is implicated in cell cycle 
control, the control of the coordination of cell cycle progression with morphological 
changes and in hyperosmotic stress response, interacts with Orb6 (51). Skb1 as well as 
Orb6 genetically interact with the S. pombe p21-activated kinase Pak1/Shk1 (49,51). 
Skb1 affects the localisation of Orb6 (51). The NDR family kinase Orb6 interacts 
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genetically and physically with Mob2. The phenotypes of Mob2 mutants and Mob2 
overexpression are identical to the ones described for Orb6 (52). Mob2 binds directly 
to the N-terminal domain of Orb6 (48), a domain that is highly conserved in all NDR 
family kinases.  
Taken together, Mob proteins in budding and fission yeast are components of 
important signalling networks, which are involved in the coordination of the cell cycle 
with cell morphology. Mob proteins interact directly with NDR-family kinases and 
they act as activating subunits of these kinases, similar to the role cyclins play in 
regulating cyclin dependent kinases. 
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Fig.3: Conserved components of the RAM, Orb6 and NDR pathway in S. 
cerevisiae, S. pombe and H. sapiens. Cbk1/Orb6/NDR kinase binds to Mob proteins. 
This interaction is important for kinase activation. A Ste20 like kinase (Kic1/MST3) is 
supposed to be responsible for the phosphorylation of the hydrophobic motif site. The 
Tao3/Mor2/hFURRY proteins act most likely as scaffolding proteins. 
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4. Role of Mob in other organisms:  
Proteins related to the components of the MEN, SIN and RAM networks are well 
conserved throughout the eukaryotic world. It is therefore likely that similar networks 
exist in other organisms. In human cells, NDR kinase physically interacts with MOB 
proteins. MOB proteins function as kinase activating subunits of human NDR kinase 
(53, 54). To date, nothing is published about a role for MOB proteins in cell cycle 
regulation and cell morphology in mammalians, insects and nematodes. But 
preliminary results in our lab point to a role for the MOB regulated kinase NDR in the 
control of the cell cycle and cell division: NDR activity and phosphorylation of its 
hydrophobic motif site Thr-444 is tightly cell cycle regulated. Activity and Thr-444 
phosphorylation increases at the G1/S boundary and persists until mitosis and 
cytokinesis. Mouse embryonic fibroblasts derived from NDR1 knockout mice display 
severe proliferation defects, including delayed entry into S-phase accompanied by 
reduced expression of cyclin A, and decelerated mitosis. Elimination of NDR2 in 
mouse embryonic fibroblasts from NDR1 knockout mice leads to an exacerbation of 
the proliferation blocks, extensive cell death and to accumulation of polyploid and 
multinucleated cells, which is due to cytokinesis defects. (R. Tamaskovic et al, 
manuscript in preparation.). Human Mob1 was found to be localized to centrosomes 
(55). These data indicate that mammalian MOB proteins, by regulating NDR kinase, 
may have a similar role as the yeast MOB proteins in the regulation of the cell cycle 
and cell division.  
The protein kinases LATS (large tumor suppressor) 1 and LATS2 are members of the 
NDR family of kinases as well; they localize to the mitotic apparatus and the 
centrosomes, respectively, and are involved in the regulation of the cell cycle and 
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apoptosis (56-60). Furthermore, LATS1 localizes to the actomyosin contractile ring 
during cytokinesis, and colocalizes with and binds to LIM kinase 1. LATS1 
knockdown affects cytokinesis (61). But to date, there is no genetic or physical 
interaction between LATS and Mob proteins reported. On the other hand, Drosophila 
Lats kinase was shown to be in a pathway with Hippo (62-64), a Ste20 like kinase 
related to human MST2 and MST1. MST kinases are related to the MEN, SIN and 
RAM kinases Cdc15, Sid1 and Kic1. But confusingly, it was shown that hippo 
phosphorylates a part of the Drosophila Lats kinase that is not conserved in any other 
NDR family kinase (62).  
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5. Mechanism of activation of NDR kinase by MOB proteins. 
NDR kinases belong to the AGC group of serine/threonine kinases. Human NDR1 and 
NDR2 are activated by phosphorylation of the activation segment site, Ser-281/282, 
and the hydrophobic motif site in the C-terminal domain, Thr-444/442 (66,67). The 
activation segment site is autophosphorylated, while the hydrophobic motif site is 
phosphorylated by a not yet identified upstream kinase (68). The signals that activate 
NDR kinase are not yet known. Treatment of cells with the protein phosphatase 
inhibitor PP2A induces activation of NDR kinase (66,67). Activation is in vivo 
dependent on Ca2+, and the Ca2+-binding protein S100B binds to a sequence in the N-
terminal domain and activates NDR kinase in vitro (68,69). 
It is shown that the human Mob proteins MOB1A, MOB1B and MOB2 interact with 
NDR kinase 1 and 2. The interaction of MOB1A with NDR is dependent on okadaic 
acid induced modification of MOB1A (54) MOB1A and MOB2 stimulate NDR kinase 
activity. (53, 54). MOB1A bind to the N-terminal domain of NDR, the SMA (S100 
and MOB association) domain (54). The SMA domain is highly conserved among 
NDR family members which interact with MOB, and the S. pombe NDR kinases Orb6 
and Sid2 interact with Mob proteins through their N-terminal domain as well (48) 
Highly conserved residues within the N-terminal domain are essential for NDR 
activity and interaction with MOB (54). A 30-60 amino acid insert between 
subdomains VII and VIII interrupts the kinase domain of all NDR family kinases. 
These insert act autoinhibitory, since the mutation of this AIS (auto inhibitory 
sequence) mutation leads to kinase activation in vitro. NDR with mutated AIS has a 
kinase activity similar to wild type NDR stimulated by MOB1A, and it cannot be 
significantly further stimulated by addition of MOB1A. These indicate that MOB1A 
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acts by inducing a conformational change that leads to the release of the 
autoinhibition. Furthermore, the AIS mutant has, apart from the increased kinase 
activity, an increased phosphorylation of Thr-444 in vivo (54). The release of the 
autoinhibition therefore facilitated phosphorylation by the Thr-444 upstream kinase. 
Interestingly, it is known for the S. cerevisiae NDR family kinase Dbf2 that binding of 
Mob1 facilitates phosphorylation by the Ste20 like kinase Cdc15 (17).  
NDR kinase phosphorylated on the hydrophopic motif site Thr-444 is localised mainly 
to the cytoplasm, and hMOB1A and hMOB1B is found mainly in the cytoplasma as 
well, while hMOB2 localises to the cytoplasm and nucleus. All of these three hMOB 
isoforms co-localise with NDR in the cytoplasma and at certain sites at the plama 
membrane. Nuclear targeted NDR1 recruits hMOB1 to the nucleus. The co-
localisation is dependent on the ability of NDR to bind to hMOB1, since a NDR form 
mutated on a residue that is important for MOB binding is important for co-
localisation. Membrane targetting of NDR activates NDR kinase activity 
constitutively, and overexpression of hMOB1 further stimulates NDR kinase activity. 
Membrane targeting of hMOB1 leads to recruitment of NDR kinase to the plasma 
membrane and rapid stimulation of NDR kinase activity and phosphorylation on Ser-
281 and Thr-444. These data suggest an in vivo model for NDR activation through 
rapid recruitment to the plasma membrane by hMOB proteins (Hergovich et al, 
manuscript in preparation). 
The three dimensional structure of hMob1A has been solved by X-ray cristallography 
(70) and the one of the closely related Xenopus MOB1 by nuclear magnetic resonance 
(71). The core structure of these MOB proteins consists of a four-helix bundle that is 
stabilized by a bound zinc atom. The N-terminal helix of this bundle is solvent 
exposed and forms together with adjacent secondary structure elements an 
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evolutionary conserved surface. This surface is negatively charged and may interact 
with basic regions of NDR. Interestingly, S. cerevisiae Mob1 mutations that affect the 
biological function of Mob1 are localized on this surface, either affecting its charge or 
structure. For example, the acidic residue Glu-151 of S. cerevisiae Mob1 is changed in 
mutants that are unable to interact with Dbf2, and the corresponding conserved residue 
Glu-50 is situated on the negatively charged surface in hMOB1 (70,71).  
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Fig.4. Model of NDR activation. A) Inactive state: Ser-281 and Thr-444 
dephosphorylated by PP2A, insert in the catalytic domain prevents Ser-281 
phosphorylation, MOB is perhaps bound to another protein X and, therefore, cannot 
bind to NDR. B) OA-induced modification of MOB enables MOB to interact with the 
N-terminal domain of NDR. C) MOB binding induces conformational change of 
NDR, thereby releasing the autoinhibitory effect of the insert. This increases 
autophosphorylation and the kinase activity of NDR. Phosphorylation of T444 by an 
upstream kinase leads to a fully activated kinase. 
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6. Concluding remarks 
Mob proteins act as kinase activating subunits for kinases of the NDR family. They 
are involved in pathways that are important for the coordination of cell division with 
the cell cycle as well as for the regulation of cell polarity. Many questions concerning 
the role of a possible MEN- or RAM- like network in mammalian cells remain to be 
answered. Further investigation of these networks in mammalian systems is required 
for a better understanding of mammalian cellular biology. This could open new 
possibilities for drug development. NDR kinases and interacting proteins may be 
involved in tumor development: NDR1 mRNA is upregulated in highly necrotic and 
progressive ductal carcinoma in situ of the breast (DCIS) (72), and NDR kinase 
activity is elevated in several melanoma cell lines (69). NDR2 mRNA is upregulated 
in the highly metastatic non-small cell lung cancer cell line NCH-H460 (73). The 
mRNA encoding human Mob2 is upregulated in hepatocellular carcinomas (53,74). 
These findings suggest a role for NDR protein kinase in the regulation of cancer cell 
morphology and migration. 
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6. Aim of the study 
The human serine/threonine kinases NDR1 and NDR2 are members of the AGC group 
of kinases. Human NDR kinases belong to a kinase family that is highly conserved 
throughout the eukaryotic world. Members of this kinase family are implicated in the 
regulation of cell morphology and the cell cycle (Tamaskovich et al, 2003). In S. 
cerevisiae, signalling networks (RAM, MEN), implicating the NDR kinases Cbk1 and 
Dbf2, were discovered (Nelson et al, 2003, Bardin and Amon, 2001). The components 
of these networks are highly conserved proteins as well. The aim of the work 
presented herein was to further elucidate the activation mechanism of NDR kinase. 
Based on the high conservation of the components of the RAM and MEN networks, 
we investigated the effect of hMOB1, a conserved protein whose yeast relatives are 
part of the RAM and MEN signalling networks, on NDR kinase activity. Thereby we 
developed a new model for the activation mechanism of NDR kinases by MOB 
proteins, which act as kinase activating subunits. Furthermore, we further refined the 
phosphorylation mechanism of NDR, showing that NDR is phosphorylated on the 
activation segment site by autophosphorylation and on the hydrophobic motif site by 
an upstream kinase, and that both phosphorylations are Ca2+- dependent. 
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7. Results 
7.1 Mechanism of Activation of NDR kinase by the hMOB1 protein 
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Summary 
NDR (nuclear Dbf2-related) kinase belongs to a family of kinases that is highly 
conserved throughout the eukaryotic world. We showed previously that NDR is 
regulated by phosphorylation and the Ca2+ binding protein S100B. The budding 
yeast relatives of Homo sapiens NDR, Cbk1 and Dbf2, were shown to interact 
with Mob2 (Mps one binder 2) and Mob1, respectively. This interaction is 
required for the activity and biological function of these kinases. In this present 
study, we show that hMOB1, the closest relative of yeast Mob1 and Mob2, 
stimulates NDR kinase activity and interacts with NDR both in vivo and in vitro. 
Point mutations of highly conserved residues within the N-terminal domain of 
NDR reduced NDR kinase activity as well as hMOB1 binding. A special feature 
of NDR kinases is an insert within the catalytic domain between subdomains VII 
and VIII. A sequence within this insert shows a high basic amino acid content in 
all kinases of the NDR family known to interact with MOB proteins. We show 
that this sequence is autoinhibitory, and our data indicate that binding of hMOB1 
to the N-terminal domain of NDR induces the release of this autoinhibition. 
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Introduction 
NDR kinase1 belongs to a highly conserved family of kinases, a subclass of the 
AGC (protein kinase A, G and C) group of kinases (1,2). The NDR family 
consists of the mammalian protein kinases NDR1 and NDR2, Drosophila 
melanogaster NDR, Caenorhabditis elegans SAX1, mammalian, D. melanogaster 
and C. elegans large tumour suppressor (LATS) kinases, Neurospora crassa 
COT1, Ustilago maydis UKC1, Saccharomyces cerevisiae Cbk1, Dbf2 and 
Dbf20, Schizosaccharomyces pombe Orb6 and Sid2, and several plant kinases 
(1,2). These kinases share a high sequence conservation and some possess 
conserved functions, mainly involving regulation of cell morphology and the cell 
cycle (2-15). 
The kinase domain sequence of NDR is related to that of other members of the 
AGC group of kinases, e.g. PKA, PKG, PKCs, PRK, p70S6K, p90RSK and PDK1 
(1). NDR contains all 12 subdomains of the kinase catalytic domain as described 
by Hanks and Hunter (16). However, the catalytic domains of all members of the 
NDR family are interrupted by an insert of 30 − 60 amino acids between 
subdomains VII and VIII. This inserted sequence is not well conserved but is 
always rich in the basic amino acids arginine and lysine. The catalytic domain 
insert has been shown to act as a non-consensus nuclear localisation signal in the 
case of NDR1: NDR1 localises predominantly to the nucleus in COS1 cells, 
whereas mutant NDR1 with a deletion in the insert is localised to the cytosol (17). 
A further special feature of NDR-family kinases is an highly conserved N-
terminal domain. In the case of NDR1, this domain consists of 81 amino acids and 
encompasses a region predicted to form an amphiphilic α-helix that binds to the 
EF-hand Ca2+ binding protein S100B (18). Finally, the C-terminal extension of 
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NDR kinase contains a broadly conserved hydrophobic motif phosphorylation site 
that is an important regulatory site within the AGC group of protein kinases (19). 
NDR kinase is efficiently (20 to 100-fold) activated upon treatment of cells with 
the PP2A inhibitor okadaic acid (OA). OA treatment induces phosphorylation of 
the activation segment site Ser-281 and the hydrophobic motif site Thr-444 (20). 
We have shown that Ser-281 is autophosphorylated, whereas Thr-444 is targeted 
by an as yet unidentified upstream kinase. Both sites are crucial for NDR activity 
in vivo and in vitro. NDR activation is Ca2+ dependent, as shown by treatment of 
COS1 cells with the Ca2+ chelator BAPTA-AM, which abolishes NDR activation. 
It has been shown that the EF-hand Ca2+ binding protein S100B binds to the N-
terminal domain of NDR in vivo and in vitro and that Ca2+/S100B activates NDR 
in vitro. S100B induces increased autophosphorylation on Ser-281. During 
investigations of the mechanism of S100B-induced autophosphorylation, a third 
autophosphorylation site, Thr-74 in the N-terminal domain, was discovered (21). 
This site is also crucial for NDR activation, since its mutation to alanine affected 
NDR activity in vivo. 
The results of several recent studies indicate a novel, conserved signalling 
pathway involving NDR kinase family members. It has been shown in D. 
melanogaster that NDR genetically interacts with FURRY, a 300-kDa protein of 
unknown function (22). In S. cerevisiae, the FURRY relative Tao3/Pag1 lies on 
the Cbk1 pathway. Furthermore, Tao3/Pag1 and Cbk1 interact physically and 
their localisation is interdependent (23). In S. pombe, the FURRY-like protein 
Mor2/Cps12 interacts physically with Orb6, the S. pombe NDR orthologue (24). 
The FURRY-like proteins are conserved in mammals and, thus, it is likely that 
other proteins interacting genetically and/or physically with S. cerevisiae Cbk1 or 
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Dbf2 also play a role in the NDR kinase family pathway in higher eukaryotes. 
Most of these proteins are fairly well conserved throughout evolution.  
S. cerevisiae Mob1 is a member of the mitotic exit network (MEN) (25, 26). Dbf2 
associates with Mob1, and Mob1 is required for phosphorylation and activation of 
Dbf2 (27). S. cerevisiae Mob2, a close relative of Mob1, is a member of the Cbk1 
pathway. Mob2 is required for the biological function of Cbk1 in mother/daughter 
separation after cytokinesis and maintenance of polarised cell growth. Mob2 
associates physically with Cbk1, and Cbk1 kinase activity is dependent on Mob2. 
Furthermore, Mob2 and Cbk1 show interdependent localisation (28, 29). 
Similarly, S. pombe Mob2 interacts physically with the protein kinase Orb6 and is 
required for Orb6 function in the coordination of cell polarity with the cell cycle 
(30). Multicellular organisms possess highly conserved MOB proteins. hMOB1α 
shares a sequence identity/similarity of 50/65% with S. cerevisiae Mob2 and of 
57/78% with S. pombe Mob1. The human MOB protein family consists of two 
almost identical proteins, hMOB1α and hMOB1β, (Gi8922671 and 27735029) 
sharing a sequence identity/similarity of 95/97%, a more distantly related protein, 
hMOB2 (Gi 38091156) that is 41/60% identical/similar to hMOB1α, three other 
related proteins, hMOB3 α, β and γ, (Gi18677731, 41350330 and 3809115) with 
an identity/similarity of about 50/73% to hMOB1α, and the weakly similar 
protein phocein (Gi41349451) that is 24/45% identical/similar to hMOB1α. Since 
the nomenclature of MOB proteins in the databases is rather confusing, we use the 
above terminology based on homology as also proposed recently by Stravridi et 
al. (31). To date, no functional domains have been identified in MOB proteins and 
the hMOB proteins have no known functions. It has been shown that the MOB 
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relative phocein interacts with the PP2A regulatory subunit striatin and with 
proteins involved in vesicular traffic (32,33). 
Here, we characterise the interaction of hMOB1α, the closest relative of yeast 
Mob1 and Mob2, with human NDR kinase. We show that hMOB1 binding is 
dependent on the N-terminal domain of NDR and that hMOB1 stimulates NDR 
kinase activity both in vivo and in vitro. Furthermore, we show that a basic 
sequence within the insert in the catalytic domain of NDR has an autoinhibitory 
function and that hMOB1 may stimulate NDR activity by releasing the 
autoinhibitory effect of this sequence. 
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Experimental procedures 
Cell culture − COS-1 cells were maintained in Dulbecco’s modified Eagle’s 
medium containing 10% FCS, 100 U/ml penicillin and 100 µg/ml streptomycin. 
Cells were transfected at the subconfluent stage with Fugene-6 transfection 
reagent (Roche) according to the manufacturer’s instructions. In some 
experiments, the cells were treated for 60 min with 1µM OA in 0.1% N,N-
dimethylformamide (DMF) or 50 µM BAPTA-AM in 0.1% DMSO 48 h after 
transfection. 
 
Plasmids −  Mammalian expression vector pCMV5 encoding HA-tagged NDR1 
was described previously (21). pCMV5-hMOB1α was constructed by PCR using 
the Image clone 4854541 (BG 754693) as template and the primers 5`GGG GTA 
CCA CCA TGG AAC AGA AAC TCA TCT CTG AAG AGG ATC TGA GCT 
TCC TCT TCA GCA GCC GCT C3’ and 5’GCT CTA GAC ATT TAT CTG 
TCT TTT GAT CCA AGT TTC TCT ATT AAT TCT TGA AGA GG3`, and 
subcloned into the KpnI and the XbaI sites of the vector. pGex2T-hMOB1 was 
constructed by PCR using the primers 5’CGG GAT CCA GCT TCC TCT TCA 
GCA GCC GCT C3’ and 5’CCG CTC GAG CAT TTA TCT GTC TTT TGA 
TCC AAG TTT CTC TAT TAA TTC TTG AAG AGG3’ and subcloned into the 
BamH1 and XhoI sites of the vector. For the bacterial production of NDR protein 
kinase, NDR2 was fused to a capsid-stabilising protein of lambdoid phage 21 
(SHP)2. The cloning details and vector maps are available upon request. pCMV5 
HA-NDR1 and pSHP-NDR2 point mutations were generated from wild-type 
vectors using the QuickChange site mutagenesis protocol (Stratagene) and 
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appropriate primers (primer sequences upon request). Sequences of all plasmids 
were confirmed by DNA sequencing.  
 
Antibodies − Anti-Ser-281P and anti-Thr-444P antibodies were as described 
previously (21). Anti-Thr-74P rabbit polyclonal antiserum was raised against the 
synthetic peptide AHARKET(PO4)EFLRLK. The 12CA5 (HA) and the 9E10 
(myc) monoclonal antibody hybridoma supernatants were used for detection of 
HA-NDR and myc-hMOB1. Anti-GST-NDR polyclonal antibody was as 
described previously (17). 
 
Western blotting − To detect HA-NDR, SHP-NDR and myc-hMOB1, samples 
were resolved by 10% or 12% SDS-PAGE and transferred to PVDF membranes. 
Membranes were blocked in TBST (50 mM Tris-HCl pH 7.5, 150 mM NaCl and 
0.05% Tween-20) containing 5% skimmed milk powder and were then probed 
overnight at 4°C with anti-GST NDR rabbit polyclonal antibody, 12CA5 (HA) 
monoclonal antibody supernatant, 9E10 anti-myc monoclonal antibody 
supernatant, anti–Thr-444P, anti-Ser-281P or anti Thr-74P. Bound antibodies 
were detected with horseradish peroxidase-linked secondary antibodies or, for 
detection of myc-hMOB1 in HA-immunoprecipitations, with HRP-conjugated 
Protein A/G, and ECL. 
 
Bacterial expression of human-GST-fused hMOB1 and -SHP-fused NDR2 − XL-1 
blue E. coli was transformed with the pGEX-2T-hMOB1 plasmid. Mid-
logarithmic phase cells were induced with 0.1 mM isopropyl β-D-
thiogalactopyranoside (IPTG) overnight at 20°C. Bacteria were disrupted using a 
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French press in the presence of 1 mg/ml lysozyme and the fusion proteins were 
purified on glutathione-agarose. SHP-NDR2 wild-type and mutant plasmids were 
transformed into XL-1 blue E. coli and the protein produced as described for 
GST-hMOB1 and purified on Ni-NTA Sepharose. 
 
HA-NDR kinase assay − Transfected COS-1 cells were washed once with ice-cold 
PBS and harvested in 1 ml ice-cold PBS containing 1 mM Na3VO4 and 20 mM β-
glycerolphosphate before lysis in 500 µl of IP buffer (20 mM Tris-HCl pH 8.0, 
150 mM NaCl, 1% Nonidet P-40, 10% glycerol, 1 mM Na3VO4, 20 mM β-
glycerolphosphate, 1 µM microcystin-LR, 50 mM NaF, 0.5 mM PMSF, 4 µM 
leupeptin, and 1 mM benzamidine. Lysates were centrifuged at 20000 g for 20 
min and duplicate aliquots (250 µg) of supernatant were precleared with protein 
A-Sepharose for 60 min and mixed subsequently for 3 h at 4°C with 12CA5 
antibody prebound to protein A-Sepharose. The beads were then washed twice 
with IP buffer, once for 10 min with IP buffer containing 1 M NaCl, again for 10 
min with IP buffer, and finally twice with 20 mM Tris-HCl pH 7.5 containing 4 
µM leupeptin and 1 mM benzamidine. Thereafter, beads were resuspended in 30 
µl buffer containing 20 mM Tris-HCl pH 7.5, 10 mM MgCl2, 1 mM DTT, 100 
µM [γ-32P]ATP (~1,000 cpm/pmol), 1 µM cAMP-dependent protein kinase 
inhibitor peptide, 4 µM leupeptin, 1 mM benzamidine, 1 µM microcystin-LR and 
1 mM NDR1 substrate peptide (KKRNRRLSVA). After 60 min incubation at 
30°C, the reactions were processed as described previously (21). 
 
SHP-NDR kinase assay −  1 µg purified recombinant SHP-NDR wild type and 
mutants (without further treatment or pre-autophosphorylated in the presence of 
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10 µM GST-hMOB1 or GST) were assayed in a 30 µl reaction mixture containing 
20 mM Tris-HCl pH 7.5, 10 mM MgCl2, 1 mM DTT, 100 µM [γ-32P]ATP (~1,000 
cpm/pmol) and 1 mM NDR1 substrate peptide (KKRNRRLSVA).  After 
incubation at 30°C, reactions were processed and kinase activity determined as 
described for the HA-NDR kinase assay. 
 
Immunoprecipitations − COS-1 cells transfected with HA-NDR wild type or 
mutants and myc-hMOB1 were harvested as described above. Cell lysate protein 
(0.5 mg) was precleared with protein A or G Sepharose and mixed subsequently 
for 3 h at 4°C with 12CA5 antibody prebound to protein A Sepharose or with 
9E10-antibody prebound to protein G Sepharose. The beads were then washed 
twice with IP buffer, once with IP buffer containing 1M NaCl, once again with IP 
buffer, and finally twice with 20 mM Tris-HCl pH 7.5 containing 4 µM leupeptin 
and 1 mM benzamidine. Samples were resolved by 12% SDS-PAGE and myc-
hMOB1 and HA-NDR detected by western blotting. 
 
GST pull down − 25 µg aliquots of GST or GST-hMOB1 were incubated with 
gluthathione Sepharose for 2 h at 4°C. The beads were washed three times with 
TBS and then 5 µg aliquots of SHP-NDR wild type or mutants were added and 
incubated for 3 h at 4°C. The beads were washed five times with TBS, 
resuspended in 30 µl 1xSDS sample buffer and the samples resolved by 12% 
SDS-PAGE. NDR bound to GST-hMOB1 was detected by western blotting. 
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Results 
 
hMOB1 activates NDR in COS1 cells as well as in vitro − Previous work by 
other groups has shown in yeast that Mob1 and Mob2 are required for the activity 
of the NDR-related kinases Dbf2 and Cbk1, respectively (26, 27). To test whether 
hMOB1 also plays a role in NDR activation, we cotransfected myc-hMOB1 or the 
empty vector with HA-NDR1 into COS1 cells. The cells were treated with the 
PP2A-inhibitor OA. OA is, to date, the only known potent activator of NDR in 
vivo (20, 21) and it has been shown that yeast Mob1 becomes phosphorylated 
after OA treatment (27). The kinase activity of immunoprecipitated HA-NDR1 
was stimulated 35-fold by a 45-min 1 µM OA treatment (Fig. 1A). Coexpression 
of myc-hMOB1 induced a further two- to three-fold increase in NDR kinase 
activity (Fig.1A). At the 45 min OA time point, HA-NDR1 coexpressed with 
myc-hMOB1 was stimulated 100-fold compared to the control. This indicates a 
role for hMOB1 in NDR activation. To test whether hMOB1 acts directly on 
NDR, we performed in vitro kinase assays of bacterially expressed SHP-NDR2 in 
the presence of GST-hMOB1 or GST. We used NDR2 for in vitro experiments 
because it can be readily produced in sufficient amounts. NDR2, which is 86% 
identical to NDR1, has been shown to be regulated in the same way as NDR1 
(34). Furthermore, we confirmed with NDR1 produced in Sf9 cells that wild-type 
NDR1 behaves in vitro similar to NDR2 with respect to hMOB1 (data not shown). 
GST-hMOB1 stimulated SHP-NDR2 autophosphorylation about two-fold (data 
not shown). Furthermore, SHP-NDR2, which was pre-autophosphorylated in the 
presence of GST-hMOB1, has an up to sixfold higher kinase activity against the 
NDR substrate peptide than SHP-NDR pre-autophosphorylated in the presence of 
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GST (Fig. 1B). These results show that hMOB1 has a direct, positive effect on 
NDR kinase activity. We tested the effect of hMOB1 on the phosphorylation state 
of the NDR phosphorylation sites Thr-74, Ser-281 and Thr-444 (Thr-75, Ser-282 
and Thr-442 in the case of NDR2; the phosphorylation sites of NDR2 were 
recognised by phosphospecific antibodies generated against the corresponding 
phosphorylation sites of NDR1). SHP-NDR2 phosphorylation on the 
autophosphorylation sites Ser-282 and Thr-75 was slightly increased, whereas 
Thr-442 of SHP-NDR2, which is known to be targeted by an upstream kinase in 
vivo, showed no autophosphorylation (Fig. 1B). 
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Fig. 1. hMOB1 stimulates NDR kinase activity. A) HA-NDR was cotransfected with myc-hMOB1 
or the empty vector and treated for the indicated times with 1 µM OA. 12CA5 immunoprecipitates 
were then assayed for kinase activity. Also shown is the expression of HA-NDR and myc-hMOB1 
in the total cell lysates. B) GST-hMOB1 or GST were added to bacterially-expressed SHP-NDR2 
and autophosphorylation reactions performed for the indicated times. After autophosphorylation, 
half of the reaction was added to a mixture containing 32P-ATP and NDR substrate peptide to 
perform kinase assays. The other half was stopped with SDS sample buffer and resolved on a 10% 
SDS gel for western blots with phosphospecific antibodies. 
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hNDR1 interacts with hMOB1 − To investigate whether hMOB1, the closest 
relative of yeast MOB2 and MOB1 in mammals, is able to interact with NDR1, 
epitope-tagged NDR1 and hMOB1 were cotransfected into COS1 cells. In co-
immunoprecipitation of myc-hMOB1 with HA-NDR1 (Fig. 2A), as well as in co-
immunoprecipitation of HA-NDR with myc-hMOB1 (Fig. 2B), hMOB1 
associated with NDR1. The protein level of myc-hMOB1 was dramatically 
increased upon OA stimulation, whereas myc-hMOB1 transfected without NDR1 
was present at similar levels in OA-treated and untreated cells. We did not address 
the molecular basis of this phenomenon. The kinase dead mutant with mutated 
catalytic lysine in the ATP binding site, K118A, was still able to interact with 
hMOB1 after OA stimulation (Fig. 2A). Thus, the interaction was not dependent 
on NDR kinase activity. Furthermore, we tested whether the two important in vivo 
phosphorylation sites of NDR, Ser-281 and Thr-444, as well as a recently 
identified in vitro autophosphorylation site, Thr-74, play a role in NDR−MOB 
interaction. The NDR mutants S281A and T444A still interacted with hMOB1 
after OA stimulation, while the T74A mutant showed almost complete absence of 
interaction with hMOB1 (data not shown). 
 
NDR-hMOB1 interaction depends on OA-induced modification on hMOB1, 
while phosphorylation of NDR is not required − Myc-hMOB1 interacted with 
HA-NDR1 in OA-treated COS1 cells, but it was not clear whether OA acted just 
by increasing the myc-hMOB1 protein level or whether OA-induced modification 
of NDR1, hMOB1 or both promoted the interaction. To address this question, we  
transfected HA-NDR1 and myc-hMOB1 separately into COS1 cells and 
stimulated them with 1 µM OA or left them unstimulated. We then pooled the 
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lysates (NDR1 ± OA with hMOB1 ± OA) and immunoprecipitated with α-HA 
antibody. In the two combinations containing myc-hMOB1 of OA-treated cells, 
myc-hMOB1 strongly associated with HA-NDR, regardless of whether the HA-
NDR was expressed in OA-treated or unstimulated cells. Myc-hMOB1 from 
unstimulated cells showed only a weak interaction with HA-NDR from both 
unstimulated and OA-stimulated cells (Fig. 2C). Thus, OA-induced 
phosphorylation of NDR is not required for interaction but hMOB1 modification 
is necessary. Furthermore, GST-hMOB1 was phosphorylated by 
immunoprecipitated HA-NDR. The phosphorylation of GST-hMOB1 increased 
three- to fourfold when HA-NDR was immunoprecipitated from OA-stimulated 
COS1 cells. However, phosphorylation of GST-hMOB1 was also observed when 
kinase dead HA-NDR was immunoprecipitated (Fig. 2D). We conclude that a 
kinase that co-immunoprecipitates with NDR is able to phosphorylate hMOB1. 
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Fig. 2. NDR interacts with hMOB1. A, B) HA-NDR, wild type and kinase dead (kd), and myc-
hMOB1 were cotransfected into COS1 cells and the cells treated with OA prior to lysis. A) HA-
NDR was immunoprecipitated and the co-immunoprecipitated myc-hMOB1 detected. B) myc-
hMOB1 was immunoprecipitated and the co-immunoprecipitated HA-NDR detected. C) HA-NDR 
and myc-hMOB1 were transfected separately into COS1 cells and the cells treated with OA or 
solvent alone prior to lysis. Lysates of OA-stimulated and unstimulated cells containing HA-NDR1 
and lysates of OA-stimulated and unstimulated cells containing myc-hMOB1 were combined. HA-
NDR was immunoprecipitated from these combined lysates and co-immunoprecipitated myc-
hMOB1 was detected. D) HA-NDR wild type and the kinase dead mutant K118A were transfected 
into COS1 cells and the cells treated for 60 min with 1 µM OA or the solvent alone prior to lysis. 
HA-NDR was immunoprecipitated out of 1 mg lysate protein. HA-NDR kinase reactions were 
performed for 2 h with 10 µM GST-hMOB1 or GST instead of the NDR substrate peptide. The 
reactions were resolved on a 10% SDS-PAGE and the incorporated 32P visualised with a 
PhosphorImager.  
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The highly conserved N-terminal domain of NDR is required for kinase 
activation − The N-terminal regulatory domain of NDR kinase is highly 
conserved in the closest relatives of NDR throughout the eukaryotic world (Fig. 
3A). Several residues are completely invariant throughout evolution from single 
cell organisms to humans. This prompted us to test the functional significance of 
these residues with respect to NDR kinase activity. Mutations of highly conserved 
residues induced strong inhibition of OA-stimulated kinase activity (Fig 3B). The 
first part of the N-terminal domain covering amino acids 1 to 33 and containing a 
predicted β-sheet in hNDR proved to be important for kinase activation. Deletion 
of the first 30 amino acids completely abolished kinase activation (data not 
shown). Point mutations in this region strongly reduced kinase activity: mutation 
of Thr-16, Glu-18 and Glu-28 reduced activity to about 40%, whereas mutation of 
Lys-24 and Tyr-31 reduced activity to about 20%. Mutation to alanine of Arg-41, 
Arg-44 or Leu-48, all of which lie in a predicted first α-helix covering the amino 
acids 40-55 and are situated close together on the same side of the predicted α-
helix, reduced kinase activity to below 20% of wild-type activity. Mutation of 
residues in a predicted second α-helix situated in the previously described S100B 
binding region of NDR and covering amino acids 60-80 also led to inhibition of 
kinase activity. Mutation of Lys-72, Glu-73, Thr-74, Arg-78 and Leu-79 to 
alanine reduced kinase activity to 20% or lower. Taken together, the results imply 
that the high conservation of the N-terminal domain, further termed SMA (S100B 
and MOB Association) domain, is due to an absolute requirement of the 
conserved residues for proper kinase function, either by ensuring the correct 
structural conformation of the protein or being directly involved in the binding to 
interacting proteins. 
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Fig. 3. The N-terminal SMA domain of NDR is essential for kinase activity. A) Alignment of the 
N-terminal domain of NDR and its relatives. Numbering based on NDR1. B) Relative kinase 
activities of HA-NDR1 point mutants from OA-stimulated COS1 cells. The kinase activities of HA-
NDR and the indicated mutants were measured. The data are a summary of three experiments 
(mutants amino acids 16-31, 40-60 and 61-79). NDR wild type was stimulated 20- to 30-fold by 
OA in these experiments. The activities of the NDR mutants were compared to the activity of wild-
type NDR in each experiment. Similar expression levels of NDR wild type and mutants were 
confirmed in each experiment by HA-western blotting. 
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The SMA domain is required for NDR-MOB interaction − Thr-74, which was 
previously shown to be important for NDR kinase activity and interaction with 
S100B, also turned out to be required for NDR−hMOB1 interaction in COS1 
cells. Therefore, we investigated the involvement of the conserved residues of the 
SMA domain in NDR−hMOB1 interaction. Cotransfection of HA-tagged NDR 
mutants and myc-hMOB1 and subsequent co-immunoprecipitation of myc-MOB 
with HA-NDR revealed that several of the conserved residues important for 
kinase activation are also required for NDR−hMOB1 interaction (Fig. 4A-C). Tyr-
31, Arg-41, Thr-74 and Arg-78 seem to be absolutely required for interaction, 
while the Lys-24, Arg-44 and Leu-79 mutants displayed reduced interaction. Only 
three of the mutants with a strongly reduced kinase activity (Arg-48, Lys-72, Glu-
73) showed no decrease in ability to bind hMOB1. 
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Fig. 4. The SMA domain of NDR is required for NDR−hMOB1 interaction. HA-NDR N-terminal 
point mutants and myc-hMOB1 were cotransfected into COS1 cells that were treated with OA 
prior to lysis. HA-NDR mutants were immunoprecipitated and co-immunoprecipitated myc-
hMOB1 was detected. A) Point mutants amino acids 16-31, B) point mutants amino acids 40-60, 
C) point mutants amino acids 61-79. 
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Tyr-32 of NDR2 kinase is essential for activation by hMOB1 in vitro − The 
residues Tyr-31, Arg-41, Arg-44, Thr-74 and Arg-78 of NDR1 were shown to be 
important for kinase activation and interaction with hMOB1 in COS1 cells. We 
examined whether these residues are involved directly in the interaction of NDR 
and hMOB1 or indirectly by influencing interactions with other proteins in the 
cells. We used bacterially-produced SHP-NDR2, wild type and the mutants 
Y32A, RR4245AA, E74A, T75A and R79A (corresponding to the NDR1 mutants 
Y31A, RR4144AA, E73A, T74A and R78A), together with GST-hMOB1 protein 
to perform in vitro kinase assays to measure the direct effect of hMOB1 on NDR 
kinase activity (Fig. 5A). Mutation of Glu-74, a residue that affects kinase activity 
but not interaction with hMOB1 in COS1 cells, led to reduced kinase basal 
activity in vitro. This very highly conserved Glu-74 seems to have an important 
intrinsic role for the function of NDR kinase, although it is not involved in the 
binding to hMOB1. Mutation of residues Arg-42 and Arg-45, which lie on the 
same side of a predicted α-helix and whose mutation affects NDR−hMOB1 
interaction as well as kinase activation in COS1 cells, led to a reduction in kinase 
activity in vitro but did not completely abolish the activation by hMOB1. NDR 
with mutated Tyr-32 showed an intact basal kinase activity but was not activated 
by hMOB1 at all in vitro, pointing to an important role for this residue in the 
direct interaction with hMOB1. Activation of the T75A and the R79A mutants by 
hMOB1 was not different to wild-type NDR, suggesting that Thr-75 and Arg-79 
are not directly involved in binding to hMOB1 and do not affect the kinase 
activity of NDR per se. Furthermore, pull-down assays showed that NDR2 with 
mutated Tyr-32 does not bind to hMOB1, while the binding of NDR2 with 
mutated Arg-42 and Arg-45 is not abolished (Fig. 5B). 
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Fig. 5. Influence of SMA domain mutants on the in vitro kinase activation of NDR by hMOB1 
and the NDR−hMOB1 interaction. A) 1 µg wild-type SHP-hNDR2 and the indicated mutants was 
pre-autophosporylated in the presence of 10 µM GST-hMOB1 or GST for 2 h. The reactions were 
subsequently mixed with γ-32P-ATP and NDR substrate peptide and incubated for 60 min to 
determine the NDR peptide kinase activity. B) 25 µg GST or GST-hMOB1 was incubated with 20 
µl gluthathione Sepharose for 2 h at 4°C. The beads were washed three times with TBS and 5 µg 
SHP-NDR wild type and mutants were then added and the mixture incubated for 3 h at 4°C. The 
beads were washed five times with TBS, resuspended in 30 µl 1x SDS sample buffer and the 
samples resolved by 12% SDS PAGE. Bound NDR was detected by western blotting using the anti-
NDR antibody. 
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The insert in the catalytic domain acts as an autoinhibitory sequence − A 
common feature of the NDR family of kinases is an insert in the catalytic domain 
of 30-60 amino acids between subdomains VII and VIII. The insert sequence is 
not highly conserved, but contains in all cases many positively charged amino 
acids. Therefore, we tested the importance of these positive residues for NDR 
activity and NDR−hMOB1 interaction. Mutating the sequence amino acids 265-
KRKAETWKRNRR-276 to amino acids 265-AAAAETWAANRR-276 increased 
both kinase activity and phosphorylation of Thr-74, Ser-281 and Thr-444 in COS1 
cells (Fig. 6A, B), but did not affect NDR−MOB binding (data not shown). To test 
whether this insert sequence has an autoinhibitory function, we produced 
recombinant SHP-NDR2 insert mutant and tested its in vitro activity. NDR with 
the mutated insert sequence had a four- to six-fold elevated basal kinase activity, 
similar to hMOB1 stimulated NDR2, proving that the insert sequence is 
autoinhibitory. Moreover, NDR2 with a mutated autoinhibitory sequence (AIS) 
was only slightly, about 1.5-fold, stimulated by hMOB1. Furthermore, we 
examined the effect of the combined mutation of Tyr-32 and the AIS. Mutation of 
Tyr-32, which abolishes binding of hMOB1 to NDR, did not affect the activity of 
the AIS-mutant NDR2, and the AIS Y32A mutant was not activated by hMOB1 
(Fig. 6C). Altogether, these results indicate that hMOB1 binding induces the 
release of the autoinhibition caused by the AIS. 
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Fig. 6. Mutation of the insert in the catalytic domain activates NDR kinase. A) Kinase activity of 
HA-NDR insert mutant. The amino acid sequence 265 KRKAETWKRNRR 276 was mutated to 265 
AAAAETWAANRR 276. HA-NDR, wild type and insert mutant were expressed in COS1 cells and 
the cells treated with OA or solvent alone, as indicated. HA-NDR was immunoprecipitated and 
NDR kinase activity against the NDR substrate peptide measured. B) Western blots showing the 
expression levels (anti-HA western blot) and the phosphorylation states of Thr-74, Ser-281 and 
Thr-444. C) In vitro kinase activity of NDR insert mutant. 1 µg SHP-NDR2 wild type, insert 
mutant (AIS=autoinhibitory sequence) and insert mutant with mutated Tyr-32 were pre-
autophosphorylated in the presence of 10 µM GST-hMOB1 or GST for 2 h. Reactions were mixed 
with γ-32P-ATP and NDR substrate peptide and incubated for 60 min to determine NDR kinase 
activity. 
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The Ca2+ chelator BAPTA-AM reduces NDR-MOB interaction in cells, but 
the action of hMOB1 on NDR in vitro is Ca2+-independent − Previously, we 
showed that treatment of COS1 cells with the Ca2+ chelator BAPTA-AM reduces 
OA-induced NDR kinase activation (21). Therefore, we tested whether treatment 
of COS1 cells with BAPTA-AM influences NDR−hMOB1 interaction. In co-
immunoprecipitation of myc-hMOB1 with HA-NDR of BAPTA- and OA-treated 
cells, BAPTA-AM reduced NDR−hMOB1 interaction corresponding to the 
observed reduction in NDR kinase activation (Fig. 7A). Therefore, we tested 
whether Ca2+ influences the action of hMOB1 on NDR in vitro. Addition of Ca2+ 
to NDR in vitro kinase assays, in the presence or absence of GST-hMOB1, had no 
effect on NDR kinase activity (Fig. 7B). Thus Ca2+ has no direct influence on 
NDR−hMOB1 interaction. 
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Fig.7. Ca2+ depletion of COS1 cells reduces NDR−hMOB1 interaction but Ca2+ has no direct 
role in NDR−hMOB1 interaction A) HA-NDR1 and myc-hMOB1 were cotransfected into COS1 
cells and the cells treated with BAPTA-AM and OA or the solvents alone, as indicated. HA-NDR 
was immunoprecipitated and the co-immunoprecipitated myc-hMOB1 detected. The kinase activity 
of the HA-NDR immunoprecipitates was measured in a peptide kinase assay. 
B) 1 µg SHP-NDR2 was pre-autophosphorylated for 2 h in the presence of 10 µM GST-hMOB1 or 
GST at 0, 10, 100 and 1000 µM Ca2+. Zero Ca2+ was achieved by the addition of 2 mM EGTA to 
the kinase reactions. The reactions were subsequently mixed with γ-32P-ATP and NDR substrate 
peptide and incubated for a further 60 min to determine the peptide kinase activity of NDR. 
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Discussion 
We found that NDR kinase is activated by and interacts with hMOB1 in vitro and 
in COS1 cells. MOB proteins, similar to NDR family kinases, are highly 
conserved throughout the eukaryotic world. hMOB1 is the closest relative of yeast 
Mob1 and Mob2. The yeast NDR family kinases Dbf2 and Cbk1 were both shown 
to interact with yeast Mob1 and Mob2. The finding that hMOB1 activates and 
interacts with NDR supports the existence of a highly conserved signalling 
pathway. The interaction of NDR and hMOB1 in COS1 cells increased when cells 
were treated with OA. We have shown that interaction of NDR1 and hMOB1 in 
cell lysates depends on an OA-induced modification of hMOB1 but not of NDR. 
A possible explanation for this is that hMOB1 is sequestered by interaction with 
another protein and hMOB1 is released upon OA treatment and interacts with 
NDR. Therefore, the observed activation of NDR by OA may not be due solely to 
direct inhibition of Ser-281 and Thr-444 dephosphorylation and activation of the 
pathway leading to Thr-444 phosphorylation, but also to an increase in hMOB1 
interaction with NDR. The observed phosphorylation of GST-hMOB1 by 
immunoprecipitated wild-type and kinase dead HA-NDR1 suggests that OA 
stimulates a kinase that phosphorylates hMOB1 and is in a complex with NDR. It 
is conceivable that this phosphorylation is responsible for the binding of NDR to 
hMOB1 in COS1 cells. There is now a need to identify the phosphorylation sites 
on hMOB1 and the kinase that phosphorylates hMOB1. We showed previously 
that NDR activation depends on Ca2+ (21). Treatment of COS1 cells with the Ca2+ 
chelator BAPTA-AM led to a decrease in NDR−hMOB interaction. However, 
Ca2+ had no effect on hMOB1-stimulated NDR activity in vitro. Therefore, Ca2+ 
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may be required for MOB modification in vivo but it plays no role in the direct 
activation of NDR by MOB. 
Several residues within the N-terminal SMA domain (S100B and MOB 
association domain) of NDR are important for NDR−hMOB1 interaction and for 
the kinase activation in vivo. On the other hand, only one of these residues, Tyr-
32, proved to be important for interaction with and activation by hMOB1 in vitro. 
In contrast, it has been shown by NMR studies that X. laevis MOB1 interacts with 
a synthetic peptide covering the S100B binding region of NDR (35). This region 
also contains residues Thr-74 and Arg-78, which are important for NDR 
activation and interaction with hMOB1 in vivo. Furthermore, the previously 
resolved crystal (31) and NMR (35) structures of hMOB1α and X. laevis MOB1, 
respectively, revealed that MOB1 has a negatively charged, exposed potential 
interaction surface. Thus, it is likely that positively charged residues of the NDR 
SMA domain, such as Arg-78, are involved in the interaction with hMOB1 but 
that its mutation is not sufficient to disrupt interaction with NDR under in vitro 
conditions. The residues Arg-41 and Arg-44, which lie on the same side of a 
predicted α-helix, may also participate in the interaction but their mutation is not 
sufficient to disrupt the interaction in vitro. Mutation of Tyr-32, however, might 
disrupt the overall structure of the SMA domain, thereby disabling the interaction 
with hMOB1, or Tyr-32 of NDR might interact directly with hMOB1. 
Although the sequence of the insert in the kinase catalytic domain between 
subdomains VII and VIII is not well conserved between NDR and the yeast 
kinases Cbk1 and Dbf2, they all have a sequence with a high basic amino acid 
content. Since this sequence is located just in front of the activation segment 
phosphorylation site, the question arises of whether it has a regulatory role. 
Mutation of the basic residues in this insert led to kinase activation both in cells 
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and in vitro, showing that the sequence acts autoinhibitory. When NDR with 
mutated AIS was mutated on Tyr-32, a residue essential for NDR−hMOB1 
interaction, unstimulated kinase activity was not affected. This points to a new 
mechanism of kinase activation: binding of MOB may induce a conformational 
change that leads to release of the autoinhibition caused by the AIS. 
Crystallographic studies of MOB-bound and –unbound NDR would be required to 
test this model. It is noteworthy that phosphorylation of the hydrophobic motif 
site Thr-444 of the NDR AIS mutant in COS1 cells also increased. Thus, the 
release of autoinhibition also facilitated phosphorylation by the hydrophobic motif 
upstream kinase. In accordance with this, it was suggested previously that binding 
of yeast Mob1 to Dbf2 enables the Ste20-like kinase Cdc15 to phosphorylate 
Dbf2 (27). 
It has been shown that the autoinhibitory sequence acts as a nuclear localisation 
signal in COS1 cells in the case of NDR1 (17). In yeast, Mob2 is important for the 
localisation of the NDR relative Cbk1 (28, 29). It is possible that the 
conformational change induced by hMOB1 also influences NDR localisation and 
this will be addressed in future studies. It will also be interesting to examine 
whether other members of the MOB family (hMOB1 α,β, hMOB2, hMOB3 
α,β,γ) act as kinase activators in vivo. During preparation of this article, it has 
been reported that hMOB2 interacts with NDR1 and NDR2 from Jurkat cells and 
that hMOB2 stimulates NDR kinase activity (36). 
S100B, a previously described activator of NDR, is constitutively bound to NDR 
in cells independent of OA stimulation (21). S100B may constitutively maintain 
the correct conformation of the SMA domain. It has been shown recently that the 
NDR-derived S100B-binding peptide adopts its helical conformation after binding 
to S100B (37). A high concentration of S100B in certain cell types, for example 
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melanoma cells (18), may thus lead to constitutively elevated NDR activity. MOB 
proteins, in contrast, may transmit a signal by fluctuation of the MOB protein 
level during the cell cycle, as was reported for S. cerevisiae Mob1 (38), and/or by 
post-translational modification of MOB that promotes the interaction with NDR, 
as we have suggested for the mechanism of OA-induced NDR kinase activation. 
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N,N,N′,N′-tetraacetic acid tetra(acetoxymethyl)ester; GST, gluthathione S-
transferase; HA, hemagglutinin; DDT, dithiothreitol; OA, okadaic acid; SMA, 
S100B and MOB association; AIS, autoinhibitory sequence, wt, wild-type; PP2A, 
protein phosphatase 2A; PCR, polymerase chain reaction; ECL, enhanced chemo 
luminescence  
2
 Forrer, P., Chang, C., Ott, D., Wlodawer, A. and Plückthun, A. J. Mol. Biol.; 
submitted. 
 
Acknowledgments: 
R.T. was supported by Swiss Cancer League grant KFS 01342-02-2003. M.R.S. 
was supported by the Krebsliga beider Basel. The Friedrich Miescher Institute is 
part of the Novartis Research Foundation. 
 
 
 
 
 
 
  
94 
94 
7.2. Mechanism of Ca2+ -mediated regulation of NDR1 and NDR2 through 
autophosphorylation and phosphorylation by an upstream kinase 
In this section, I present the results which were on the basis of the publications by 
Tamaskovic et al and Stegert et al (see section 10.). 
 
7.2.1. NDR1 is phosphorylated on the activation segment site Ser-281 by 
autophosphorylation, while the hydrophobic motif site Thr-444 is 
phosphorylated by an upstream kinase 
NDR1 kinase is efficiently phosphorylated in vivo upon okadaic acid treatment on 
the activation segment site Ser-281 and the hydrophobic motif site Thr-444.  
To examine the mode of phosphorylation of these phosphorylation sites, HA-
NDR phosphorylation site mutants, kinase dead HA-NDR K118A and wild type 
HA-NDR were transfected into COS-1 cells. The COS-1 cells were treated with 
1µM OA prior to lysis. HA-NDR, wild type and the mutants were 
immunoprecipitated and the kinase activity measured. Mutation of Ser-281 as 
well as of Thr-444 reduces NDR kinase basal activity as well as the OA-
stimulated activity (A). Western blot analysis with phosphospecific antibodies 
revealed that Thr-444 is phosphorylated independent of NDR kinase activity; the 
kinase dead NDR mutant is phosphorylated on Thr-444. On the other hand, Ser-
281 phosphorylation is dependent on NDR kinase activity; the kinase dead mutant 
is not phosphorylated on Ser-281 (B). We can conclude that the activation 
segment site Ser-281 is phosphorylated by autophosphorylation, while the 
hydrophobic motif site Thr-444 is phosphorylated by an upstream kinase. 
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       A)                                                                        B) 
 
NDR1 is phosphorylated on the activation segment site Ser-281 by autophosphorylation, while 
the hydrophobic motif site Thr-444 is phosphorylated by an upstream kinase in vivo. A) COS-1 
cells expressing either wild-type HA-NDR1 or the indicated mutants were treated for 1 h with 1 
µM OA or with solvent alone. HA-tagged NDR kinase mutants were then immunoprecipitated (of 
250 µg detergent extracts) and assayed for kinase activity by a peptide kinase assay. B) 1µg of 
protein extracts from transfected COS-1 cells was immunblotted with 12CA5 to verify similar 
expression level of each HA-NDR construct (top panel). For analysis of the phosphorylation 
status, 12CA- immunoprecipitated HA-NDR1 variants were analysed by immunoblotting with 
phosphospecific antibodies directed against phosphorylated Ser-281 or phosphorylated Thr-444 
(second and third panel).  
 
 
7.2.2. NDR2 is phosphorylated on the activation segment site Ser-282 by 
autophosphorylation, while the hydrophobic motif site Thr-444 is 
phosphorylated by an upstream kinase 
The kinase domain of hNDR2 is 91% identical to hNDR1. Here we tested if the 
mode of activation of NDR2 is similar to that of NDR1. HA-NDR2, wt , 
phosphorylation site mutants and kinase dead K119A mutant, were transfected 
into COS-1 cells. The COS-1 cells were treated with 1µM OA prior to lysis. HA-
NDR, wild type and the mutants were immunoprecipitated and the kinase activity 
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measured and the phosphorylation state of Ser-282 and Thr-442 determined. The 
results lead to the same conclusions as for NDR1: The activation segment 
phosphorylation site is an autophosphorylation site, while the hydrophobic motif 
site is phophorylated by an upstream kinase. 
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NDR2 is phosphorylated on the activation segment site Ser-282 by autophosphorylation, while 
the hydrophobic motif site Thr-442 is phosphorylated by an upstream kinase in vivo.  COS-1 
cells expressing either wild-type HA-NDR2 or the indicated mutants were treated for 1 h with 1 
µM OA or with solvent alone. HA-tagged NDR kinase mutants were then immunoprecipitated (of 
250 µg detergent extracts) and assayed for kinase activity by a peptide kinase assay( top) 1µg of 
protein extracts from transfected COS-1 cells was immunblotted with 12CA5 to verify similar 
expression level of each HA-NDR construct. For analysis of the phosphorylation status, 12CA- 
immunoprecipitated HA-NDR1 variants were analysed by immunoblotting with phosphospecific 
antibodies directed against phosphorylated Ser-281 or phosphorylated Thr-444 (these antobodies 
recognise the corresponding phosphorylated residues Ser-282 and Thr-442 of NDR2).  
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7.2.3. The Ca2+ -chelator BAPTA-AM reduces NDR activity 
andphosphorylation on Ser-281 and Thr-444 
Previously, it has been shown that NDR kinase is activated by Ca2+ -dependent 
binding of S100B protein in vitro (Millward et al, 1998). Here we examined the 
importance of intracellular Ca2+ on NDR activity and Ser-281 and Thr-444 
phosphorylation. For this purpose, transfected COS-1 cells were treated with the 
membrane permeable agent BAPTA-AM, which is freely taken up into cells were 
it is hydrolysed by esterases and trapped intracellularly as the active and 
membrane impermeable Ca2+ -chelator BAPTA. The result show that treatment 
with 50 µM BAPTA-AM dramatically reduces OA induced NDR activation. The 
phosphorylation of the activation segment site Ser-281, but also of the 
hydrophobic motif site Thr-444 is reduced. Therefore, intracellular Ca2+ is 
important for the autophosphorylation of Ser-281 as well as for the 
phosphorylation of Thr-444 by an upstream kinase. 
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Phosphorylation ofr both Ser-281 and Thr-444 is dependent on intracellular Ca2+. 
HA-NDR1- expressing COS-1 cells were treated for 1h as indicated with 1 µM OA, 50 µM 
BAPTA-AM or the solvents alone. 12CA5 immunoprecipitates (of 200 µg of protein extracts) were 
then assayed by peptide kinase assay for NDR kinase activity (top). Protein extracts were 
immunblotted with the 12CA5 antibody to verify equal expression levels. For the analysis of the 
phosphorylation status, 12CA5-immunoprecipitated HA-NDR (of 200 µg of protein extract) was 
analysed by immunoblotting with the the phosphospecific antibodies directed against P-281 or P-
T444. 
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8. Discussion: 
8.1. Regulation of NDR kinases 
It has been shown that human NDR kinases possess two phosphorylation sites that 
are important for kinase activation (Millward et al, 1999). These two sites are the 
activation segment site that is phosphorylated by autophosphorylation 
(Tamaskovic et al, 2003) and the hydrophobic motif site that is phosphorylated by 
a Ste20 like kinase (Stegert et al, manuscript in preparation). Human NDR kinases 
are dephosphorylated by the action of protein phosphatase 2A (PP2A) (Millward 
et al, 1999). This phosphorylation sites are highly conserved among all members 
of the NDR kinase family. Therefore it is likely that all other members of the 
NDR family are regulated by phosphorylation/dephosphorylation on these two 
sites. Indeed, it has been shown for the budding yeast relative Dbf2 that these two 
sites are phosphorylated, essential for activity, and that the phosphorylation 
depends on the Ste20 like kinase Cdc15 (Mah et al, 2001). 
Treatment of cells with the PP2A inhibitor okadaic acid efficiently stimulates 
NDR kinase activity, but to date, nothing is known about physiological stimuli 
that induce NDR kinase activation. The budding yeast NDR kinases Dbf2 and 
Dbf20 are activated in a cell cycle dependent manner, the activity peaks after the 
metaphase to anaphase transition (Toyn et al, 2004). Interestingly, human NDR 
kinase activity is cell cycle dependent as well: Activity and hydrophobic motif 
phosphorylation increases at the G1/S boundary and persists until mitosis and 
cytokinesis. (Tamaskovic et al, manuscript in preparation). Therefore, it is likely 
that NDR kinases are not activated by an external stimulus, but rather by internal 
signals that are generated during the cell cycle.  
NDR kinase activation depends on internal Ca2+, and Ca2+-binding protein S100B 
activates NDR kinase in vitro (Millward et al, 1998, Tamaskovic et al, 2003). The 
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regulatory role of Ca2+ in vivo is not absolutely clear. Overexpression of S100B in 
COS-1 cells does not activate NDR. Treatment of COS-1 cells with a Ca2+-
ionophore stimulates NDR activity only slightly while Ca2+-depletion of COS-1 
cells leads to a dramatic reduction of NDR kinase activity and Ser-281 and Thr-
444 phosphorylation. S100B is in vivo bound to not activated as well as activated 
NDR. Nevertheless, endogenous NDR from certain melanoma cell lines with 
elevated S100B-levels shows a higher kinase activity (Millward et al, 1998). 
Therefore, S100B may be necessary to keep NDR in a correct conformation, so 
the higher activity of NDR from S100B positive melanomas may reflect a higher 
level of properly folded NDR, while S100B/Ca2+ may not fulfil a short term 
regulatory role. To date, there is nothing known about a role for Ca2+ and S100B 
related proteins for the regulation of NDR family kinases in other organisms. 
Mob proteins bind to and activate the NDR family kinases Cbk1 and Dbf2 in 
budding yeast and Orb6 and Sid2 in fission yeast. Mob proteins are, like NDR 
family kinases, highly conserved throughout the eukaryotic world. Human NDR 
kinase is activated by hMOB1, and hMOB1 binds to the N-terminal domain of 
NDR. The interaction with MOB apparently induces a conformational change, 
which induces the release of an autoinhibition. The autoinhibition is caused by an 
autoinhibitory sequence situated in the insertion in the catalytic domain. This 
insertion, which is high in basic amino acids, is characteristic for all NDR family 
kinases. The activation mechanism of NDR kinases by Mob proteins appears to be 
highly conserved during evolution.  
The budding yeast kinase Cbk1 interacts with the Ste20 like kinase Kic1 
(Jorgensen et al, 2002), and Dbf2 is phosphorylated by the Ste20 like kinase 
Cdc15. The phosphorylation of Dbf2 by Cdc15 depends on budding yeast Mob1. 
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(Mah et al, 2001). It has been shown in our lab that the Ste20-like kinase MST3 
phosphorylates NDR2 kinase at the hydrophobic motif site Thr-442 (Stegert et al,  
manuscript in preparation).  
 
 
8.2. Function of NDR kinase: 
Members of the NDR kinase family in unicellular organisms are involved in the 
regulation of cell morphology and the cell cycle (see introduction). The function 
of the NDR kinase orthologues in multicellular organisms has been previously 
investigated in D. melanogaster and C. elegans. 
 
8.2.1. D. melanogaster 
The D. melanogaster orthologue, TRC, encoded by the tricornered (trc) gene, is 
70% identical and 79% similar to human NDR kinase. Trc mutations are 
organismal recessive lethal, but cell viable. The trc mutation has been used as a 
cuticular marker in genetic screens. The Trc phenotype of genetic mosaic flies 
shows splitting, clustering, or branching of polarised structures, like epidermal 
hairs decorating the adult cuticular surface, the shafts of bristle sense organs, the 
lateral extensions of the arista, and the larval denticle (Geng et al, 2000). The 
morphology and polarity of these structures is, however, normal except for the 
region of the branch point. This is different from mutations in the frizzled tissue 
polarity pathway such as inturned or actin cytoskeleton components such as 
crinkled, singed, or forked which exhibit an altered polarity of cellular projections 
or abnormal morphology all regions of the structure (Adler and Lee, 2001). But 
Trc might interact with the actin cytoskeleton, because treatment of differentiating 
cells by cytochalasin D or latrunculin A, inhibitors of actin polymerisation, 
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phenocopied the branched hairs and bristles found in trc mutant clones. A weak 
trc mutant was hypersensitive to cytochalasin D treatment (Geng et al, 2000). But 
the treatment with these drugs also results in short, fat and occasionally 
malformed hairs and bristles, which does not occur in trc mutants. These 
differences indicate that TRC is not simply required for actin polymerisation; it is 
more likely that TRC interacts with the actin cytoskeleton in a more subtle way. 
In drosophila sensory neurons, TRC is important for the control of dendritic 
branching and tiling (tiling refers to the complete but nonredundant coverage of a 
receptive field by dendrites of functionally homologous neurons). Dendrites of trc 
mutants display excessive terminal branching and fail to avoid homologous 
dendritic branches, resulting in significant overlap of the dendritic fields (Emoto 
et al, 2004). 
 
8.2.2. C. elegans 
The C. elegans gene sax-1 encodes a protein kinase with 66% identity and 74% 
similarity to human NDR1. Sax-1 mutants are organismal viable, but they possess 
defects in neuronal cell shape and polarity. Certain types of neuronal cells of sax-
1 mutants have expanded to irregular cell bodies and initiate ectopic neurites. This 
suggests that SAX-1 functions to restrict cell and neurite growth (Zallen et al, 
2000). SAX-1 kinase is important for mechanosensory neurite termination and 
tiling. SAX-1 functions in a pathway with SAX-2, a Furry like protein. During C. 
elegans development, the posterior PLM mechanosensory dendrite overlaps with 
the anterior ALM mechanosensory neuron. The PLM process growth slows down 
during a discrete period of time, between an early period of rapid outgrowth and a 
later period of maintained growth. Thereby the overlap is eliminated. In sax-2 
mutants, anterior and posterior mechanosensory processes overlap, because the 
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growth of the PLM sensory dendrite does not slow down between the active 
growth and maintenance growth phases (Gallegos and Bargmann, 2004). 
 
 
8.2.3. Function of NDR kinases in mammalians 
 
New results from our lab point to a role for NDR kinase in the control of the cell 
cycle and cell division: NDR activity and phosphorylation of its hydrophobic 
motif site Thr-444 is tightly cell cycle regulated. Activity and Thr-444 
phosphorylation increases at the G1/S boundary and persists until mitosis and 
cytokinesis. Mouse embryonic fibroblasts derived from NDR1 knockout mice 
display severe proliferation defects, including delayed entry into S-phase 
accompanied by reduced expression of cyclin A, and decelerated mitosis. 
Elimination of NDR2 in mouse embryonic fibroblasts from NDR1 knockout mice 
leads to an exacerbation of the proliferation blocks, extensive cell death and to 
accumulation of polyploid and multinucleated cells, which is due to cytokinesis 
defects. (R. Tamaskovic et al, manuscripts in preparation.).  
Furthermore, it was shown that hNDR2 mRNA is induced in the mouse amygdala 
during fear memory consolidation. Transfection of hNDR2 in PC12 cells leads to 
decreased cell spreading and changes in neurite outgrowth (Stork et al, 2004). 
 
 
8.2.4 Role of NDR kinase in disease 
Members of the NDR kinase family are involved in the regulation of the cell cycle 
and cell morphology. Therefore, human NDR kinase may be involved in control 
of cell proliferation and cancer. The Ndr1 as well as the Ndr2 gene location 6p21  
  
105 
105 
and 12p11 respectively belong to regions that were described as cancer amplicons 
(Manning et al, 2002). NDR1 mRNA is consistently upregulated in ductal 
carcinoma in situ with intraductal necrosis (DCISnecrosis+) compared to DCIS 
without intraductal necrosis. DCISnecrosis+ cases have a higher risk of recurrence 
and/or the progression of DCIS to invasive tumors (Adeyinka et al, 2002). NDR1 
kinase was found to be hyperactivated in some S100B positive melanoma cell 
lines (Millward et al, 1998). S100B activates NDR in vitro (Tamaskovic et al, 
2003), and S100B serum levels are used as a prognostic marker for tumors with 
poor prognosis (Hauschild et al, 1999). Human NDR2 is up regulated in the 
highly metastatic non-small cell lung cancer cell line NCI-H460 (Ross et al, 
2000). Taken together, NDR kinases are involved in a signalling pathway that 
controls cell proliferation and morphology, and its deregulation may be involved 
in the pathogenesis of some malignant disorders.  
Furthermore, NDR1 and NDR2 kinases were shown to be incorporated into HIV-
1 particles. NDR1 and NDR2 were cleaved by the HIV-1 protease both within the 
virions and within the producer cells, and these truncation inhibited NDR kinase 
activity. (Devroe et al, 2005). 
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9. Conclusions and future prospects 
 
NDR kinase is highly conserved during evolution. NDR kinase is part of a novel 
conserved signalling pathway, which is implicated in the control of cell 
morphology and the cell cycle. The signalling pathway involves MOB proteins. 
The results presented in this thesis describe a new mechanism of kinase regulation 
by MOB proteins. Binding of MOB to the SMA (S100 and MOB association)-
domain of NDR induces the release of the autoinhibition that is caused by the 
autoinhibitory sequence (AIS) and thereby stimulates NDR kinase activity.  
In the future, the identity and function of other components of the NDR signalling 
pathway will be unravelled. For example, the kinase that phosphorylates the 
hydrophobic motif site has been identified as the Ste-20 like kinase MST3 
(Stegert et al, manuscript in preparation). The function of other proteins which are 
orthologues of components of the yeast RAM-signalling network, like the human 
Furry-like protein, need to be investigated.  
NDR family kinases are involved in the regulation of cell morphology and the cell 
cycle. The most important future task will be to unravel the function of 
mammalian NDR1 and NDR2 kinase. New results in our lab show that NDR is 
cell cycle regulated and seem to play a role in cell cycle progression. Further work 
will be required to investigate the exact role of NDR in the cell cycle. The 
physiological role of NDR is also investigated by the use of NDR1 and NDR2 
knockout mice. There was no phenotype detected so far for the NDR1 single 
knockout mice, therefore it is likely that the two isoforms compensate each other. 
The NDR2 and the double knockout will help to shed light on the physiological 
function of NDR kinase.  
  
107 
107 
 
10. References 
 
Abraham, R.T. (2002) Identification of TOR signaling complexes: more TORC 
for the cell growth engine. Cell, 111, 9-12. 
 
Adeyinka, A., Emberley, E., Niu, Y., Snell, L., Murphy, L.C., Sowter, H., 
Wykoff, C.C., Harris, A.L. and Watson, P.H. (2002) Analysis of gene expression 
in ductal carcinoma in situ of the breast. Clin Cancer Res, 8, 3788-3795. 
 
Asakawa, K., Yoshida, S., Otake, F. and Toh-e, A. (2001) A novel functional 
domain of Cdc15 kinase is required for its interaction with Tem1 GTPase in 
Saccharomyces cerevisiae. Genetics, 157, 1437-1450. 
 
Baillat, G., Gaillard, S., Castets, F. and Monneron, A. (2002) Interactions of 
phocein with nucleoside-diphosphate kinase, Eps15, and Dynamin I. J Biol Chem, 
277, 18961-18966. 
 
Baillat, G., Moqrich, A., Castets, F., Baude, A., Bailly, Y., Benmerah, A. and 
Monneron, A. (2001) Molecular cloning and characterization of phocein, a protein 
found from the Golgi complex to dendritic spines. Mol Biol Cell, 12, 663-673. 
 
Baker, S.J. and Reddy, E.P. (1996) Transducers of life and death: TNF receptor 
superfamily and associated proteins. Oncogene, 12, 1-9. 
 
Balasubramanian, M.K., McCollum, D., Chang, L., Wong, K.C., Naqvi, N.I., He, 
X., Sazer, S. and Gould, K.L. (1998) Isolation and characterization of new fission 
yeast cytokinesis mutants. Genetics, 149, 1265-1275. 
 
Balendran, A., Hare, G.R., Kieloch, A., Williams, M.R. and Alessi, D.R. (2000) 
Further evidence that 3-phosphoinositide-dependent protein kinase-1 (PDK1) is 
required for the stability and phosphorylation of protein kinase C (PKC) isoforms. 
FEBS Lett, 484, 217-223. 
 
Bardin, A.J. and Amon, A. (2001) Men and sin: what's the difference? Nat Rev 
Mol Cell Biol, 2, 815-826. 
 
Bardin, A.J., Boselli, M.G. and Amon, A. (2003) Mitotic exit regulation through 
distinct domains within the protein kinase Cdc15. Mol Cell Biol, 23, 5018-5030. 
 
Becker, W. and Joost, H.G. (1999) Structural and functional characteristics of 
Dyrk, a novel subfamily of protein kinases with dual specificity. Prog Nucleic 
Acid Res Mol Biol, 62, 1-17. 
 
Belham, C., Wu, S. and Avruch, J. (1999) Intracellular signalling: PDK1--a kinase 
at the hub of things. Curr Biol, 9, R93-96. 
 
  
108 
108 
Bhalla, U.S. and Iyengar, R. (1999) Emergent properties of networks of biological 
signaling pathways. Science, 283, 381-387. 
 
Bhattacharya, S., Large, E., Heizmann, C.W., Hemmings, B. and Chazin, W.J. 
(2003) Structure of the Ca2+/S100B/NDR kinase peptide complex: insights into 
S100 target specificity and activation of the kinase. Biochemistry, 42, 14416-
14426. 
 
Bichsel, S.J., Tamaskovic, R., Stegert, M.R. and Hemmings, B.A. (2004) 
Mechanism of activation of NDR (nuclear Dbf2-related) protein kinase by the 
hMOB1 protein. J Biol Chem, 279, 35228-35235. 
 
Bidlingmaier, S., Weiss, E.L., Seidel, C., Drubin, D.G. and Snyder, M. (2001) 
The Cbk1p pathway is important for polarized cell growth and cell separation in 
Saccharomyces cerevisiae. Mol Cell Biol, 21, 2449-2462. 
 
Blondeau, C., Gaillard, S., Ternaux, J.P., Monneron, A. and Baude, A. (2003) 
Expression and distribution of phocein and members of the striatin family in 
neurones of rat peripheral ganglia. Histochem Cell Biol, 119, 131-138. 
 
Casey, P.J. and Gilman, A.G. (1988) G protein involvement in receptor-effector 
coupling. J Biol Chem, 263, 2577-2580. 
 
Cenamor, R., Jimenez, J., Cid, V.J., Nombela, C. and Sanchez, M. (1999) The 
budding yeast Cdc15 localizes to the spindle pole body in a cell-cycle-dependent 
manner. Mol Cell Biol Res Commun, 2, 178-184. 
 
Colman-Lerner, A., Chin, T.E. and Brent, R. (2001) Yeast Cbk1 and Mob2 
activate daughter-specific genetic programs to induce asymmetric cell fates. Cell, 
107, 739-750. 
 
Cong, J., Geng, W., He, B., Liu, J., Charlton, J. and Adler, P.N. (2001) The furry 
gene of Drosophila is important for maintaining the integrity of cellular 
extensions during morphogenesis. Development, 128, 2793-2802. 
 
Conti, M. and Jin, S.L. (1999) The molecular biology of cyclic nucleotide 
phosphodiesterases. Prog Nucleic Acid Res Mol Biol, 63, 1-38. 
 
Cooper, M., Johnston, L.H. and Beggs, J.D. (1995) Identification and 
characterization of Uss1p (Sdb23p): a novel U6 snRNA-associated protein with 
significant similarity to core proteins of small nuclear ribonucleoproteins. Embo J, 
14, 2066-2075. 
 
Devroe, E., Erdjument-Bromage, H., Tempst, P. and Silver, P.A. (2004) Human 
Mob Proteins Regulate the NDR1 and NDR2 Serine-Threonine Kinases. J Biol 
Chem, 279, 24444-24451. 
 
Devroe, E. and Silver, P.A. (2002) Retrovirus-delivered siRNA. BMC Biotechnol, 
2, 15. 
 
  
109 
109 
Devroe, E., Silver, P.A. and Engelman, A. (2005) HIV-1 incorporates and 
proteolytically processes human NDR1 and NDR2 serine-threonine kinases. 
Virology, 331, 181-189. 
 
Donovan, J.D., Toyn, J.H., Johnson, A.L. and Johnston, L.H. (1994) P40SDB25, a 
putative CDK inhibitor, has a role in the M/G1 transition in Saccharomyces 
cerevisiae. Genes Dev, 8, 1640-1653. 
 
Du, L.L. and Novick, P. (2002) Pag1p, a novel protein associated with protein 
kinase Cbk1p, is required for cell morphogenesis and proliferation in 
Saccharomyces cerevisiae. Mol Biol Cell, 13, 503-514. 
 
Dumitrescu, T.P. and Saunders, W.S. (2002) The FEAR Before MEN: networks 
of mitotic exit. Cell Cycle, 1, 304-307. 
 
Durrenberger, F. and Kronstad, J. (1999) The ukc1 gene encodes a protein kinase 
involved in morphogenesis, pathogenicity and pigment formation in Ustilago 
maydis. Mol Gen Genet, 261, 281-289. 
 
Elledge, S.J. (1996) Cell cycle checkpoints: preventing an identity crisis. Science, 
274, 1664-1672. 
 
Emoto, K., He, Y., Ye, B., Grueber, W.B., Adler, P.N., Jan, L.Y. and Jan, Y.N. 
(2004) Control of dendritic branching and tiling by the Tricornered-kinase/Furry 
signaling pathway in Drosophila sensory neurons. Cell, 119, 245-256. 
 
Fanto, M. and McNeill, H. (2004) Planar polarity from flies to vertebrates. J Cell 
Sci, 117, 527-533. 
 
Fankhauser, C. and Simanis, V. (1993) The Schizosaccharomyces pombe cdc14 
gene is required for septum formation and can also inhibit nuclear division. Mol 
Biol Cell, 4, 531-539. 
 
Fankhauser, C. and Simanis, V. (1994) The cdc7 protein kinase is a dosage 
dependent regulator of septum formation in fission yeast. Embo J, 13, 3011-3019. 
 
Feng, J., Park, J., Cron, P., Hess, D. and Hemmings, B.A. (2004) Identification of 
a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase. 
J Biol Chem, 279, 41189-41196. 
 
Fesquet, D., Fitzpatrick, P.J., Johnson, A.L., Kramer, K.M., Toyn, J.H. and 
Johnston, L.H. (1999) A Bub2p-dependent spindle checkpoint pathway regulates 
the Dbf2p kinase in budding yeast. Embo J, 18, 2424-2434. 
 
Fitzpatrick, P.J., Toyn, J.H., Millar, J.B. and Johnston, L.H. (1998) DNA 
replication is completed in Saccharomyces cerevisiae cells that lack functional 
Cdc14, a dual-specificity protein phosphatase. Mol Gen Genet, 258, 437-441. 
 
Frenz, L.M., Lee, S.E., Fesquet, D. and Johnston, L.H. (2000) The budding yeast 
Dbf2 protein kinase localises to the centrosome and moves to the bud neck in late 
mitosis. J Cell Sci, 113 Pt 19, 3399-3408. 
  
110 
110 
Furge, K.A., Cheng, Q.C., Jwa, M., Shin, S., Song, K. and Albright, C.F. (1999) 
Regions of Byr4, a regulator of septation in fission yeast, that bind Spg1 or Cdc16 
and form a two-component GTPase-activating protein with Cdc16. J Biol Chem, 
274, 11339-11343. 
 
Gallegos, M.E. and Bargmann, C.I. (2004) Mechanosensory Neurite Termination 
and Tiling Depend on SAX-2 and the SAX-1 Kinase. Neuron, 44, 239-249. 
 
Geng, W., He, B., Wang, M. and Adler, P.N. (2000) The tricornered gene, which 
is required for the integrity of epidermal cell extensions, encodes the Drosophila 
nuclear DBF2-related kinase. Genetics, 156, 1817-1828. 
 
Grandin, N. and Charbonneau, M. (1999) Dbf2 is implicated in a Cbt1-dependent 
pathway following a shift from glucose to galactose or non-fermentable carbon 
sources in Saccharomyces cerevisiae. Mol Gen Genet, 261, 402-407. 
Grandin, N., de Almeida, A. and Charbonneau, M. (1998) The Cdc14 phosphatase 
is functionally associated with the Dbf2 protein kinase in Saccharomyces 
cerevisiae. Mol Gen Genet, 258, 104-116. 
 
Griffioen, G. and Thevelein, J.M. (2002) Molecular mechanisms controlling the 
localisation of protein kinase A. Curr Genet, 41, 199-207. 
 
Guertin, D.A., Chang, L., Irshad, F., Gould, K.L. and McCollum, D. (2000) The 
role of the sid1p kinase and cdc14p in regulating the onset of cytokinesis in 
fission yeast. Embo J, 19, 1803-1815. 
 
Hanks, S.K. and Hunter, T. (1995) Protein kinases 6. The eukaryotic protein 
kinase superfamily: kinase (catalytic) domain structure and classification. Faseb 
J, 9, 576-596. 
 
Hanks, S.K. and Quinn, A.M. (1991) Protein kinase catalytic domain sequence 
database: identification of conserved features of primary structure and 
classification of family members. Methods Enzymol, 200, 38-62. 
 
Hardie, D.G., Carling, D. and Carlson, M. (1998) The AMP-activated/SNF1 
protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev 
Biochem, 67, 821-855. 
 
Hauschild, A., Engel, G., Brenner, W., Glaser, R., Monig, H., Henze, E. and 
Christophers, E. (1999) S100B protein detection in serum is a significant 
prognostic factor in metastatic melanoma. Oncology, 56, 338-344. 
 
Hirata, D., Kishimoto, N., Suda, M., Sogabe, Y., Nakagawa, S., Yoshida, Y., 
Sakai, K., Mizunuma, M., Miyakawa, T., Ishiguro, J. and Toda, T. (2002) Fission 
yeast Mor2/Cps12, a protein similar to Drosophila Furry, is essential for cell 
morphogenesis and its mutation induces Wee1-dependent G(2) delay. Embo J, 21, 
4863-4874. 
 
Hou, M.C., Guertin, D.A. and McCollum, D. (2004) Initiation of cytokinesis is 
controlled through multiple modes of regulation of the Sid2p-Mob1p kinase 
complex. Mol Cell Biol, 24, 3262-3276. 
  
111 
111 
 
Hou, M.C., Wiley, D.J., Verde, F. and McCollum, D. (2003) Mob2p interacts with 
the protein kinase Orb6p to promote coordination of cell polarity with cell cycle 
progression. J Cell Sci, 116, 125-135. 
 
Hou, M.C., Salek, J. and McCollum, D. (2000) Mob1p interacts with the Sid2p 
kinase and is required for cytokinesis in fission yeast. Curr Biol, 10, 619-622. 
 
Hunter, T. (1995) Protein kinases and phosphatases: the yin and yang of protein 
phosphorylation and signaling. Cell, 80, 225-236. 
 
Hunter, T. (1995) When is a lipid kinase not a lipid kinase? When it is a protein 
kinase. Cell, 83, 1-4. 
 
Hwa Lim, H., Yeong, F.M. and Surana, U. (2003) Inactivation of Mitotic Kinase 
Triggers Translocation of MEN Components to Mother-Daughter Neck in Yeast. 
Mol Biol Cell. 
 
Janeway, C.A., Jr., Dianzani, U., Portoles, P., Rath, S., Reich, E.P., Rojo, J., Yagi, 
J. and Murphy, D.B. (1989) Cross-linking and conformational change in T-cell 
receptors: role in activation and in repertoire selection. Cold Spring Harb Symp 
Quant Biol, 54 Pt 2, 657-666. 
 
Jaspersen, S.L., Charles, J.F., Tinker-Kulberg, R.L. and Morgan, D.O. (1998) A 
late mitotic regulatory network controlling cyclin destruction in Saccharomyces 
cerevisiae. Mol Biol Cell, 9, 2803-2817. 
 
Jimenez, J., Cid, V.J., Cenamor, R., Yuste, M., Molero, G., Nombela, C. and 
Sanchez, M. (1998) Morphogenesis beyond cytokinetic arrest in Saccharomyces 
cerevisiae. J Cell Biol, 143, 1617-1634. 
 
Jimenez, J., Cid, V.J., Nombela, C. and Sanchez, M. (2001) A single-copy 
suppressor of the Saccharomyces cerevisae late-mitotic mutants cdc15 and dbf2 is 
encoded by the Candida albicans CDC14 gene. Yeast, 18, 849-858. 
 
Johnson, L.N., Noble, M.E. and Owen, D.J. (1996) Active and inactive protein 
kinases: structural basis for regulation. Cell, 85, 149-158. 
 
Johnston, L.H., Eberly, S.L., Chapman, J.W., Araki, H. and Sugino, A. (1990) 
The product of the Saccharomyces cerevisiae cell cycle gene DBF2 has homology 
with protein kinases and is periodically expressed in the cell cycle. Mol Cell Biol, 
10, 1358-1366. 
 
Jones, S.M. and Kazlauskas, A. (2001) Growth factor-dependent signaling and 
cell cycle progression. FEBS Lett, 490, 110-116. 
 
Jorgensen, P., Nelson, B., Robinson, M.D., Chen, Y., Andrews, B., Tyers, M. and 
Boone, C. (2002) High-resolution genetic mapping with ordered arrays of 
Saccharomyces cerevisiae deletion mutants. Genetics, 162, 1091-1099. 
 
  
112 
112 
Justice, R.W., Zilian, O., Woods, D.F., Noll, M. and Bryant, P.J. (1995) The 
Drosophila tumor suppressor gene warts encodes a homolog of human myotonic 
dystrophy kinase and is required for the control of cell shape and proliferation. 
Genes Dev, 9, 534-546. 
 
Jwa, M. and Song, K. (1998) Byr4, a dosage-dependent regulator of cytokinesis in 
S. pombe, interacts with a possible small GTPase pathway including Spg1 and 
Cdc16. Mol Cells, 8, 240-245. 
 
Kapeller, R. and Cantley, L.C. (1994) Phosphatidylinositol 3-kinase. Bioessays, 
16, 565-576. 
 
Karin, M. and Hunter, T. (1995) Transcriptional control by protein 
phosphorylation: signal transmission from the cell surface to the nucleus. Curr 
Biol, 5, 747-757. 
 
Keegan, A.D. and Zamorano, J. (1998) Regulation of gene expression, growth, 
and cell survival by IL-4: contribution of multiple signaling pathways. Cell Res, 8, 
1-13. 
 
Kitada, K., Johnson, A.L., Johnston, L.H. and Sugino, A. (1993) A multicopy 
suppressor gene of the Saccharomyces cerevisiae G1 cell cycle mutant gene dbf4 
encodes a protein kinase and is identified as CDC5. Mol Cell Biol, 13, 4445-4457. 
 
Knighton, D.R., Zheng, J.H., Ten Eyck, L.F., Ashford, V.A., Xuong, N.H., 
Taylor, S.S. and Sowadski, J.M. (1991) Crystal structure of the catalytic subunit 
of cyclic adenosine monophosphate-dependent protein kinase. Science, 253, 407-
414. 
 
Knighton, D.R., Zheng, J.H., Ten Eyck, L.F., Xuong, N.H., Taylor, S.S. and 
Sowadski, J.M. (1991) Structure of a peptide inhibitor bound to the catalytic 
subunit of cyclic adenosine monophosphate-dependent protein kinase. Science, 
253, 414-420. 
 
Knust, E. (2001) G protein signaling and asymmetric cell division. Cell, 107, 125-
128. 
 
Komarnitsky, S.I., Chiang, Y.C., Luca, F.C., Chen, J., Toyn, J.H., Winey, M., 
Johnston, L.H. and Denis, C.L. (1998) DBF2 protein kinase binds to and acts 
through the cell cycle-regulated MOB1 protein. Mol Cell Biol, 18, 2100-2107. 
 
Krebs, E.G. (1983) Historical perspectives on protein phosphorylation and a 
classification system for protein kinases. Philos Trans R Soc Lond B Biol Sci, 302, 
3-11. 
 
Lee, J.H., Van Montagu, M. and Verbruggen, N. (1999) A highly conserved 
kinase is an essential component for stress tolerance in yeast and plant cells. Proc 
Natl Acad Sci U S A, 96, 5873-5877. 
 
  
113 
113 
Lee, S.E., Frenz, L.M., Wells, N.J., Johnson, A.L. and Johnston, L.H. (2001) 
Order of function of the budding-yeast mitotic exit-network proteins Tem1, 
Cdc15, Mob1, Dbf2, and Cdc5. Curr Biol, 11, 784-788. 
 
Lee, S.E., Jensen, S., Frenz, L.M., Johnson, A.L., Fesquet, D. and Johnston, L.H. 
(2001) The Bub2-dependent mitotic pathway in yeast acts every cell cycle and 
regulates cytokinesis. J Cell Sci, 114, 2345-2354. 
 
Lin, H.Y., Wang, X.F., Ng-Eaton, E., Weinberg, R.A. and Lodish, H.F. (1992) 
Expression cloning of the TGF-beta type II receptor, a functional transmembrane 
serine/threonine kinase. Cell, 68, 775-785. 
 
Liscovitch, M., Czarny, M., Fiucci, G. and Tang, X. (2000) Phospholipase D: 
molecular and cell biology of a novel gene family. Biochem J, 345 Pt 3, 401-415. 
 
Liu, C.C., Chou, Y.L. and Ch'ang, L.Y. (2004) Down-regulation of human NDR 
gene in megakaryocytic differentiation of erythroleukemia K562 cells. J Biomed 
Sci, 11, 104-116. 
 
Liu, H.Y., Badarinarayana, V., Audino, D.C., Rappsilber, J., Mann, M. and Denis, 
C.L. (1998) The NOT proteins are part of the CCR4 transcriptional complex and 
affect gene expression both positively and negatively. Embo J, 17, 1096-1106. 
 
Liu, H.Y., Chiang, Y.C., Pan, J., Chen, J., Salvadore, C., Audino, D.C., 
Badarinarayana, V., Palaniswamy, V., Anderson, B. and Denis, C.L. (2001) 
Characterization of CAF4 and CAF16 reveals a functional connection between the 
CCR4-NOT complex and a subset of SRB proteins of the RNA polymerase II 
holoenzyme. J Biol Chem, 276, 7541-7548. 
 
Liu, H.Y., Toyn, J.H., Chiang, Y.C., Draper, M.P., Johnston, L.H. and Denis, C.L. 
(1997) DBF2, a cell cycle-regulated protein kinase, is physically and functionally 
associated with the CCR4 transcriptional regulatory complex. Embo J, 16, 5289-
5298. 
 
Luca, F.C., Mody, M., Kurischko, C., Roof, D.M., Giddings, T.H. and Winey, M. 
(2001) Saccharomyces cerevisiae Mob1p is required for cytokinesis and mitotic 
exit. Mol Cell Biol, 21, 6972-6983. 
 
Luca, F.C. and Winey, M. (1998) MOB1, an essential yeast gene required for 
completion of mitosis and maintenance of ploidy. Mol Biol Cell, 9, 29-46. 
 
Mah, A.S., Jang, J. and Deshaies, R.J. (2001) Protein kinase Cdc15 activates the 
Dbf2-Mob1 kinase complex. Proc Natl Acad Sci U S A, 98, 7325-7330. 
 
Manning, G., Plowman, G.D., Hunter, T. and Sudarsanam, S. (2002) Evolution of 
protein kinase signaling from yeast to man. Trends Biochem Sci, 27, 514-520. 
 
Manning, G., Whyte, D.B., Martinez, R., Hunter, T. and Sudarsanam, S. (2002) 
The protein kinase complement of the human genome. Science, 298, 1912-1934. 
 
  
114 
114 
Marks, J., Fankhauser, C. and Simanis, V. (1992) Genetic interactions in the 
control of septation in Schizosaccharomyces pombe. J Cell Sci, 101 ( Pt 4), 801-
808. 
 
 
McCollum, D. and Gould, K.L. (2001) Timing is everything: regulation of mitotic 
exit and cytokinesis by the MEN and SIN. Trends Cell Biol, 11, 89-95. 
 
Menssen, R., Neutzner, A. and Seufert, W. (2001) Asymmetric spindle pole 
localization of yeast Cdc15 kinase links mitotic exit and cytokinesis. Curr Biol, 
11, 345-350. 
 
Millward, T., Cron, P. and Hemmings, B.A. (1995) Molecular cloning and 
characterization of a conserved nuclear serine(threonine) protein kinase. Proc Natl 
Acad Sci U S A, 92, 5022-5026. 
 
Millward, T.A., Heizmann, C.W., Schafer, B.W. and Hemmings, B.A. (1998) 
Calcium regulation of Ndr protein kinase mediated by S100 calcium-binding 
proteins. Embo J, 17, 5913-5922. 
 
Millward, T.A., Hess, D. and Hemmings, B.A. (1999) Ndr protein kinase is 
regulated by phosphorylation on two conserved sequence motifs. J Biol Chem, 
274, 33847-33850. 
 
Moreno, C.S., Lane, W.S. and Pallas, D.C. (2001) A mammalian homolog of 
yeast MOB1 is both a member and a putative substrate of striatin family-protein 
phosphatase 2A complexes. J Biol Chem, 276, 24253-24260. 
 
Morishita, T., Mitsuzawa, H., Nakafuku, M., Nakamura, S., Hattori, S. and 
Anraku, Y. (1995) Requirement of Saccharomyces cerevisiae Ras for completion 
of mitosis. Science, 270, 1213-1215. 
 
Myers, M.P., Pass, I., Batty, I.H., Van der Kaay, J., Stolarov, J.P., Hemmings, 
B.A., Wigler, M.H., Downes, C.P. and Tonks, N.K. (1998) The lipid phosphatase 
activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci U 
S A, 95, 13513-13518. 
 
Nairn, A.C. (1990) Role of Ca2+/calmodulin-dependent protein phosphorylation 
in signal transduction. Adv Second Messenger Phosphoprotein Res, 24, 202-205. 
 
Nelson, B., Kurischko, C., Horecka, J., Mody, M., Nair, P., Pratt, L., Zougman, 
A., McBroom, L.D., Hughes, T.R., Boone, C. and Luca, F.C. (2003) RAM: a 
conserved signaling network that regulates Ace2p transcriptional activity and 
polarized morphogenesis. Mol Biol Cell, 14, 3782-3803. 
 
Ohkura, H., Hagan, I.M. and Glover, D.M. (1995) The conserved 
Schizosaccharomyces pombe kinase plo1, required to form a bipolar spindle, the 
actin ring, and septum, can drive septum formation in G1 and G2 cells. Genes 
Dev, 9, 1059-1073. 
 
  
115 
115 
Parker, P.J. and Parkinson, S.J. (2001) AGC protein kinase phosphorylation and 
protein kinase C. Biochem Soc Trans, 29, 860-863. 
 
Parkes, V. and Johnston, L.H. (1992) SPO12 and SIT4 suppress mutations in 
DBF2, which encodes a cell cycle protein kinase that is periodically expressed. 
Nucleic Acids Res, 20, 5617-5623. 
 
Ponchon, L., Dumas, C., Kajava, A.V., Fesquet, D. and Padilla, A. (2004) NMR 
solution structure of Mob1, a mitotic exit network protein and its interaction with 
an NDR kinase peptide. J Mol Biol, 337, 167-182. 
 
Racki, W.J., Becam, A.M., Nasr, F. and Herbert, C.J. (2000) Cbk1p, a protein 
similar to the human myotonic dystrophy kinase, is essential for normal 
morphogenesis in Saccharomyces cerevisiae. Embo J, 19, 4524-4532. 
 
Ross, D.T., Scherf, U., Eisen, M.B., Perou, C.M., Rees, C., Spellman, P., Iyer, V., 
Jeffrey, S.S., Van de Rijn, M., Waltham, M., Pergamenschikov, A., Lee, J.C., 
Lashkari, D., Shalon, D., Myers, T.G., Weinstein, J.N., Botstein, D. and Brown, 
P.O. (2000) Systematic variation in gene expression patterns in human cancer cell 
lines. Nat Genet, 24, 227-235. 
 
Russo, A.A., Jeffrey, P.D. and Pavletich, N.P. (1996) Structural basis of cyclin-
dependent kinase activation by phosphorylation. Nat Struct Biol, 3, 696-700. 
 
Salimova, E., Sohrmann, M., Fournier, N. and Simanis, V. (2000) The S. pombe 
orthologue of the S. cerevisiae mob1 gene is essential and functions in signalling 
the onset of septum formation. J Cell Sci, 113 ( Pt 10), 1695-1704. 
 
Schlossmann, J., Feil, R. and Hofmann, F. (2003) Signaling through NO and 
cGMP-dependent protein kinases. Ann Med, 35, 21-27. 
 
Schmidt, S., Sohrmann, M., Hofmann, K., Woollard, A. and Simanis, V. (1997) 
The Spg1p GTPase is an essential, dosage-dependent inducer of septum formation 
in Schizosaccharomyces pombe. Genes Dev, 11, 1519-1534. 
 
Schneper, L., Krauss, A., Miyamoto, R., Fang, S. and Broach, J.R. (2004) The 
Ras/protein kinase A pathway acts in parallel with the Mob2/Cbk1 pathway to 
effect cell cycle progression and proper bud site selection. Eukaryot Cell, 3, 108-
120. 
 
Seger, R. and Krebs, E.G. (1995) The MAPK signaling cascade. Faseb J, 9, 726-
735. 
 
Shah, R., Jensen, S., Frenz, L.M., Johnson, A.L. and Johnston, L.H. (2001) The 
Spo12 protein of Saccharomyces cerevisiae: a regulator of mitotic exit whose cell 
cycle-dependent degradation is mediated by the anaphase-promoting complex. 
Genetics, 159, 965-980. 
 
Shirayama, M., Matsui, Y. and Toh, E.A. (1994) The yeast TEM1 gene, which 
encodes a GTP-binding protein, is involved in termination of M phase. Mol Cell 
Biol, 14, 7476-7482. 
  
116 
116 
 
 
 
Shou, W., Azzam, R., Chen, S.L., Huddleston, M.J., Baskerville, C., 
Charbonneau, H., Annan, R.S., Carr, S.A. and Deshaies, R.J. (2002) Cdc5 
influences phosphorylation of Net1 and disassembly of the RENT complex. BMC 
Mol Biol, 3, 3. 
 
Shou, W., Seol, J.H., Shevchenko, A., Baskerville, C., Moazed, D., Chen, Z.W., 
Jang, J., Charbonneau, H. and Deshaies, R.J. (1999) Exit from mitosis is triggered 
by Tem1-dependent release of the protein phosphatase Cdc14 from nucleolar 
RENT complex. Cell, 97, 233-244. 
 
 
Sparks, C.A., Morphew, M. and McCollum, D. (1999) Sid2p, a spindle pole body 
kinase that regulates the onset of cytokinesis. J Cell Biol, 146, 777-790. 
 
St John, M.A., Tao, W., Fei, X., Fukumoto, R., Carcangiu, M.L., Brownstein, 
D.G., Parlow, A.F., McGrath, J. and Xu, T. (1999) Mice deficient of Lats1 
develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction. Nat 
Genet, 21, 182-186. 
 
Stachowiak, M.K., Fang, X., Myers, J.M., Dunham, S.M., Berezney, R., Maher, 
P.A. and Stachowiak, E.K. (2003) Integrative nuclear FGFR1 signaling (INFS) as 
a part of a universal "feed-forward-and-gate" signaling module that controls cell 
growth and differentiation. J Cell Biochem, 90, 662-691. 
 
Stavridi, E.S., Harris, K.G., Huyen, Y., Bothos, J., Verwoerd, P.M., Stayrook, 
S.E., Pavletich, N.P., Jeffrey, P.D. and Luca, F.C. (2003) Crystal structure of a 
human Mob1 protein: toward understanding Mob-regulated cell cycle pathways. 
Structure (Camb), 11, 1163-1170. 
 
Stegert, M.R., Tamaskovic, R., Bichsel, S.J., Hergovich, A. and Hemmings, B.A. 
(2004) Regulation of NDR2 protein kinase by multi-site phosphorylation and the 
S100B calcium-binding protein. J Biol Chem, 279, 23806-23812. 
 
Stegmeier, F., Visintin, R. and Amon, A. (2002) Separase, polo kinase, the 
kinetochore protein Slk19, and Spo12 function in a network that controls Cdc14 
localization during early anaphase. Cell, 108, 207-220. 
 
Stork, O., Zhdanov, A.V., Kudersky, A., Yoshikawa, T., Obata, K. and Pape, H.C. 
(2004) Neuronal functions of the novel serine / threonine kinase Ndr2. J Biol 
Chem. 
 
Surana, U., Amon, A., Dowzer, C., McGrew, J., Byers, B. and Nasmyth, K. 
(1993) Destruction of the CDC28/CLB mitotic kinase is not required for the 
metaphase to anaphase transition in budding yeast. Embo J, 12, 1969-1978. 
 
Taha, C. and Klip, A. (1999) The insulin signaling pathway. J Membr Biol, 169, 
1-12. 
 
  
117 
117 
Tamaskovic, R., Bichsel, S.J. and Hemmings, B.A. (2003) NDR family of AGC 
kinases--essential regulators of the cell cycle and morphogenesis. FEBS Lett, 546, 
73-80. 
 
Tamaskovic, R., Bichsel, S.J., Rogniaux, H., Stegert, M.R. and Hemmings, B.A. 
(2003) Mechanism of Ca2+-mediated regulation of NDR protein kinase through 
autophosphorylation and phosphorylation by an upstream kinase. J Biol Chem, 
278, 6710-6718. 
 
Tan, M., Liang, A., Brunen-Nieweler, C. and Heckmann, K. (2001) Programmed 
translational frameshifting is likely required for expressions of genes encoding 
putative nuclear protein kinases of the ciliate Euplotes octocarinatus. J Eukaryot 
Microbiol, 48, 575-582. 
 
Toyn, J.H., Araki, H., Sugino, A. and Johnston, L.H. (1991) The cell-cycle-
regulated budding yeast gene DBF2, encoding a putative protein kinase, has a 
homologue that is not under cell-cycle control. Gene, 104, 63-70. 
 
Toyn, J.H., Johnson, A.L., Donovan, J.D., Toone, W.M. and Johnston, L.H. 
(1997) The Swi5 transcription factor of Saccharomyces cerevisiae has a role in 
exit from mitosis through induction of the cdk-inhibitor Sic1 in telophase. 
Genetics, 145, 85-96. 
 
Toyn, J.H., Johnson, A.L. and Johnston, L.H. (1995) Segregation of unreplicated 
chromosomes in Saccharomyces cerevisiae reveals a novel G1/M-phase 
checkpoint. Mol Cell Biol, 15, 5312-5321. 
 
Toyn, J.H. and Johnston, L.H. (1993) Spo12 is a limiting factor that interacts with 
the cell cycle protein kinases Dbf2 and Dbf20, which are involved in mitotic 
chromatid disjunction. Genetics, 135, 963-971. 
 
Toyn, J.H. and Johnston, L.H. (1994) The Dbf2 and Dbf20 protein kinases of 
budding yeast are activated after the metaphase to anaphase cell cycle transition. 
Embo J, 13, 1103-1113. 
 
Trautmann, S., Wolfe, B.A., Jorgensen, P., Tyers, M., Gould, K.L. and 
McCollum, D. (2001) Fission yeast Clp1p phosphatase regulates G2/M transition 
and coordination of cytokinesis with cell cycle progression. Curr Biol, 11, 931-
940. 
 
Tripodis, N., Palmer, S., Phillips, S., Milne, S., Beck, S. and Ragoussis, J. (2000) 
Construction of a high-resolution 2.5-Mb transcript map of the human 6p21.2-
6p21.3 region immediately centromeric of the major histocompatibility complex. 
Genome Res, 10, 454-472. 
 
Vaudry, D., Stork, P.J., Lazarovici, P. and Eiden, L.E. (2002) Signaling pathways 
for PC12 cell differentiation: making the right connections. Science, 296, 1648-
1649. 
 
Verde, F., Wiley, D.J. and Nurse, P. (1998) Fission yeast orb6, a ser/thr protein 
kinase related to mammalian rho kinase and myotonic dystrophy kinase, is 
  
118 
118 
required for maintenance of cell polarity and coordinates cell morphogenesis with 
the cell cycle. Proc Natl Acad Sci U S A, 95, 7526-7531. 
 
Verma, R., Annan, R.S., Huddleston, M.J., Carr, S.A., Reynard, G. and Deshaies, 
R.J. (1997) Phosphorylation of Sic1p by G1 Cdk required for its degradation and 
entry into S phase. Science, 278, 455-460 
 
Visintin, R. and Amon, A. (2001) Regulation of the mitotic exit protein kinases 
Cdc15 and Dbf2. Mol Biol Cell, 12, 2961-2974. 
 
Visintin, R., Craig, K., Hwang, E.S., Prinz, S., Tyers, M. and Amon, A. (1998) 
The phosphatase Cdc14 triggers mitotic exit by reversal of Cdk-dependent 
phosphorylation. Mol Cell, 2, 709-718. 
 
Weiss, E.L., Kurischko, C., Zhang, C., Shokat, K., Drubin, D.G. and Luca, F.C. 
(2002) The Saccharomyces cerevisiae Mob2p-Cbk1p kinase complex promotes 
polarized growth and acts with the mitotic exit network to facilitate daughter cell-
specific localization of Ace2p transcription factor. J Cell Biol, 158, 885-900. 
 
Weng, G., Bhalla, U.S. and Iyengar, R. (1999) Complexity in biological signaling 
systems. Science, 284, 92-96. 
 
Williams, M.R., Arthur, J.S., Balendran, A., van der Kaay, J., Poli, V., Cohen, P. 
and Alessi, D.R. (2000) The role of 3-phosphoinositide-dependent protein kinase 
1 in activating AGC kinases defined in embryonic stem cells. Curr Biol, 10, 439-
448. 
 
Xu, T., Wang, W., Zhang, S., Stewart, R.A. and Yu, W. (1995) Identifying tumor 
suppressors in genetic mosaics: the Drosophila lats gene encodes a putative 
protein kinase. Development, 121, 1053-1063. 
 
Yang, J., Cron, P., Good, V.M., Thompson, V., Hemmings, B.A. and Barford, D. 
(2002) Crystal structure of an activated Akt/protein kinase B ternary complex 
with GSK3-peptide and AMP-PNP. Nat Struct Biol, 9, 940-944. 
 
Yang, J., Cron, P., Thompson, V., Good, V.M., Hess, D., Hemmings, B.A. and 
Barford, D. (2002) Molecular mechanism for the regulation of protein kinase 
B/Akt by hydrophobic motif phosphorylation. Mol Cell, 9, 1227-1240. 
 
Yarden, O., Plamann, M., Ebbole, D.J. and Yanofsky, C. (1992) cot-1, a gene 
required for hyphal elongation in Neurospora crassa, encodes a protein kinase. 
Embo J, 11, 2159-2166. 
 
Yoshida, S., Asakawa, K. and Toh-e, A. (2002) Mitotic exit network controls the 
localization of Cdc14 to the spindle pole body in Saccharomyces cerevisiae. Curr 
Biol, 12, 944-950. 
 
Yoshida, S. and Toh-e, A. (2001) Regulation of the localization of Dbf2 and 
mob1 during cell division of saccharomyces cerevisiae. Genes Genet Syst, 76, 
141-147. 
 
  
119 
119 
Zachariae, W., Schwab, M., Nasmyth, K. and Seufert, W. (1998) Control of cyclin 
ubiquitination by CDK-regulated binding of Hct1 to the anaphase promoting 
complex. Science, 282, 1721-1724. 
 
Zallen, J.A., Peckol, E.L., Tobin, D.M. and Bargmann, C.I. (2000) Neuronal cell 
shape and neurite initiation are regulated by the Ndr kinase SAX-1, a member of 
the Orb6/COT-1/warts serine/threonine kinase family. Mol Biol Cell, 11, 3177-
3190. 
 
Zinn, K. (2004) Dendritic tiling; new insights from genetics. Neuron, 44, 211-213. 
  
120 
120 
11.Curriculum Vitae 
 
Name:   Bichsel 
Vorname:  Samuel 
Adresse  Im Surinam 91, 4058 Basel 
Geburtsdatum: 5.5.1970 
Geburtsort:  Grenchen 
Heimatort:  Hasle BE 
 
 
Berufstätigkeit: 11/00-02/05 Doktorarbeit, FMI, Gruppe Dr. Brian A. 
Hemmings 
08/96-10/96 Temporäranstellung, Siegfried AG, Zofingen 
04/95-09/95 Pharmabiologielaborant, Ciba, 75% 
04/91-04/95 Pharmabiologielaborant, Ciba, 100% 
04/88-04/91 Berufslehre Pharmabiologielaborant, Ciba-
Geigy, Basel 
 
 
Studium:  11/00-04/05 Doktoratsstudium, Biochemie, Basel (Dr. Brian 
   
A. Hemmings, Prof. Tom Bickle, Prof. Patrick Matthias)
 
10/96-11/00 Studium Biologie 2, Basel 
 
 
Schulbildung: 11/91-2/96 Maturavorbereitung AKAD Zürich 
(Fernunterricht) 
04/88-04/91 Gewerbeschule Basel 
   04/84-04/88 Bezirksschule Grenchen 
04/78-04/84 Primarschule Grenchen 
 
 
Abschlüsse:  2005: Doktorat Biochemie 
2000: Diplom, Biologie 2 
1996: eidg. Matur, Typus C 
1991: eidg. Fähigkeitszeugnis Pharmabiologielaborant 
 
Publications: 
 
Bichsel, S.J., Tamaskovic, R., Stegert, M.R. and Hemmings, B.A. (2004) 
Mechanism of activation of NDR (nuclear Dbf2-related) protein kinase by the 
hMOB1 protein. J Biol Chem, 279, 35228-35235. 
 
Tamaskovic, R., Bichsel, S.J., Rogniaux, H., Stegert, M.R. and Hemmings, B.A. 
(2003) Mechanism of Ca2+-mediated regulation of NDR protein kinase through 
autophosphorylation and phosphorylation by an upstream kinase. J Biol Chem, 
278, 6710-6718. 
 
Tamaskovic, R., Bichsel, S.J. and Hemmings, B.A. (2003) NDR family of AGC 
kinases--essential regulators of the cell cycle and morphogenesis. FEBS Lett, 546, 
73-80. 
 
Stegert, M.R., Tamaskovic, R., Bichsel, S.J., Hergovich, A. and Hemmings, B.A. 
(2004) Regulation of NDR2 protein kinase by multi-site phosphorylation and the 
S100B calcium-binding protein. J Biol Chem, 279, 23806-23812 
